ONTOLOGY REPORT - ANNOTATIONS
| Term: | 17alpha-ethynylestradiol |
|
| Accession: | CHEBI:4903
|
browse the term
|
| Definition: | A 17-hydroxy steroid that has formula C20H24O2. |
| Synonyms: | exact_synonym: | 17alpha-ethynylestra-1,3,5(10)-triene-3,17beta-diol |
| | related_synonym: | 17-ethinyl-3,17-estradiol; 17-ethinyl-3,17-oestradiol; 17-ethinylestradiol; 17alpha-Ethinyl estradiol; C20H24O2; Ethinyl estradiol; Ethinylestradiol; Ethynyl estradiol; InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1; InChIKey=BFPYWIDHMRZLRN-SLHNCBLASA-N; [H][C@]12CC[C@@]3(C)[C@@]([H])(CC[C@@]3(O)C#C)[C@]1([H])CCc1cc(O)ccc21; ethinyloestradiol |
| | xref_casrn: | 57-63-6 |
| | xref: | ChEMBL:131241 "ChEMBL COMPOUND"; ChemIDplus:2419975 "Beilstein Registry Number"; ChemIDplus:57-63-6 "CAS Registry Number"; DrugBank:DB00977 "DrugBank"; KEGG COMPOUND:57-63-6 "CAS Registry Number"; KEGG COMPOUND:C07534 "KEGG COMPOUND"; LIPID MAPS:LMST02010036 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D004997 |
|
|
17alpha-ethynylestradiol
|
| G |
Abca6 |
ATP-binding cassette, subfamily A (ABC1), member 6 |
|
increases expression |
ISO |
10 |
99,626,334 |
99,693,870 |
RGD:6480464 |
CTD |
| G |
Abca6 |
ATP-binding cassette, subfamily A (ABC1), member 6 |
|
multiple interactions |
ISO |
10 |
99,626,334 |
99,693,870 |
RGD:6480464 |
CTD |
| G |
Acyp2 |
acylphosphatase 2, muscle type |
|
multiple interactions |
ISO |
14 |
111,507,725 |
111,512,680 |
RGD:6480464 |
CTD |
| G |
Acyp2 |
acylphosphatase 2, muscle type |
|
multiple interactions |
ISO |
14 |
111,507,725 |
111,512,680 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
increases expression |
ISO |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
|
decreases expression |
EXP |
4 |
126,996,604 |
127,198,909 |
RGD:6480464 |
CTD |
| G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
|
affects expression |
ISO |
1 |
8,358,164 |
8,372,650 |
RGD:6480464 |
CTD |
| G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
|
multiple interactions |
ISO |
1 |
8,358,164 |
8,372,650 |
RGD:6480464 |
CTD |
| G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
|
increases expression |
ISO |
1 |
8,358,164 |
8,372,650 |
RGD:6480464 |
CTD |
| G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
increases expression |
ISO |
9 |
82,162,480 |
82,216,301 |
RGD:6480464 |
CTD |
| G |
Agfg1 |
ArfGAP with FG repeats 1 |
|
multiple interactions |
ISO |
9 |
82,162,480 |
82,216,301 |
RGD:6480464 |
CTD |
| G |
Alpp |
alkaline phosphatase, placental |
|
increases expression |
ISO |
9 |
85,885,336 |
85,888,082 |
RGD:6480464 |
CTD |
| G |
Amz2 |
archaelysin family metallopeptidase 2 |
|
affects expression |
ISO |
10 |
98,889,302 |
98,899,839 |
RGD:6480464 |
CTD |
| G |
Amz2 |
archaelysin family metallopeptidase 2 |
|
increases expression |
ISO |
10 |
98,889,302 |
98,899,839 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
increases expression |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
affects expression |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Ap1m2 |
adaptor-related protein complex 1, mu 2 subunit |
|
affects expression |
ISO |
8 |
20,385,982 |
20,396,146 |
RGD:6480464 |
CTD |
| G |
Ap1m2 |
adaptor-related protein complex 1, mu 2 subunit |
|
increases expression |
ISO |
8 |
20,385,982 |
20,396,146 |
RGD:6480464 |
CTD |
| G |
Ap1m2 |
adaptor-related protein complex 1, mu 2 subunit |
|
multiple interactions |
ISO |
8 |
20,385,982 |
20,396,146 |
RGD:6480464 |
CTD |
| G |
Ap3s2 |
adaptor-related protein complex 3, sigma 2 subunit |
|
increases expression |
ISO |
1 |
135,653,104 |
135,689,454 |
RGD:6480464 |
CTD |
| G |
Ap3s2 |
adaptor-related protein complex 3, sigma 2 subunit |
|
multiple interactions |
ISO |
1 |
135,653,104 |
135,689,454 |
RGD:6480464 |
CTD |
| G |
Apex2 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
affects expression |
ISO |
X |
39,811,484 |
39,832,225 |
RGD:6480464 |
CTD |
| G |
Apex2 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
increases expression |
ISO |
X |
39,811,484 |
39,832,225 |
RGD:6480464 |
CTD |
| G |
Apex2 |
APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
multiple interactions |
ISO |
X |
39,811,484 |
39,832,225 |
RGD:6480464 |
CTD |
| G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Arvcf |
armadillo repeat gene deleted in velo-cardio-facial syndrome |
|
multiple interactions |
ISO |
11 |
84,582,208 |
84,639,874 |
RGD:6480464 |
CTD |
| G |
Asb17 |
ankyrin repeat and SOCS box-containing 17 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Asb17 |
ankyrin repeat and SOCS box-containing 17 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
increases expression |
ISO |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Atp5o |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
multiple interactions |
ISO |
11 |
31,914,320 |
31,920,632 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
increases expression |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Bloc1s6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
|
multiple interactions |
ISO |
3 |
109,706,842 |
109,716,971 |
RGD:6480464 |
CTD |
| G |
Bloc1s6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
|
decreases expression |
ISO |
3 |
109,706,842 |
109,716,971 |
RGD:6480464 |
CTD |
| G |
Bloc1s6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
|
affects expression |
ISO |
3 |
109,706,842 |
109,716,971 |
RGD:6480464 |
CTD |
| G |
Bloc1s6 |
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
|
increases expression |
EXP |
3 |
109,706,842 |
109,716,971 |
RGD:6480464 |
CTD |
| G |
Bmp2k |
BMP-2 inducible kinase |
|
multiple interactions |
ISO |
14 |
13,937,544 |
14,001,748 |
RGD:6480464 |
CTD |
| G |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
|
increases expression |
ISO |
3 |
75,248,277 |
75,252,715 |
RGD:6480464 |
CTD |
| G |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
|
multiple interactions |
ISO |
3 |
75,248,277 |
75,252,715 |
RGD:6480464 |
CTD |
| G |
Cacna1s |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cacna1s |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cacna1s |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
affects expression |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
increases expression |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Camk1d |
calcium/calmodulin-dependent protein kinase ID |
|
multiple interactions |
ISO |
17 |
83,649,720 |
84,061,160 |
RGD:6480464 |
CTD |
| G |
Capn12 |
calpain 12 |
|
increases expression |
EXP |
1 |
83,989,000 |
84,001,059 |
RGD:6480464 |
CTD |
| G |
Capza1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
increases expression |
ISO |
2 |
200,080,802 |
200,125,881 |
RGD:6480464 |
CTD |
| G |
Capza1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
multiple interactions |
ISO |
2 |
200,080,802 |
200,125,881 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
affects expression |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
multiple interactions |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
increases expression |
ISO |
1 |
210,247,351 |
210,247,881 |
RGD:6480464 |
CTD |
| G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
|
increases expression |
ISO |
1 |
54,594,860 |
54,631,157 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
decreases expression |
ISO |
3 |
3,622,894 |
3,624,805 |
RGD:6480464 |
CTD |
| G |
Cntnap2 |
contactin associated protein-like 2 |
|
multiple interactions |
ISO |
4 |
74,277,978 |
75,440,178 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
affects expression |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
increases expression |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col6a3 |
collagen, type VI, alpha 3 |
|
multiple interactions |
ISO |
9 |
89,990,129 |
90,043,697 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
decreases expression |
EXP |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Commd1 |
copper metabolism (Murr1) domain containing 1 |
|
increases expression |
ISO |
14 |
103,571,472 |
103,667,692 |
RGD:6480464 |
CTD |
| G |
Commd1 |
copper metabolism (Murr1) domain containing 1 |
|
multiple interactions |
ISO |
14 |
103,571,472 |
103,667,692 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
increases expression |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
increases expression |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
multiple interactions |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
affects expression |
ISO |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
increases expression |
EXP |
19 |
50,313,710 |
50,378,031 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases hydroxylation |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Dchs1 |
dachsous 1 (Drosophila) |
|
decreases expression |
EXP |
1 |
163,497,340 |
163,517,217 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
affects expression |
ISO |
X |
21,498,202 |
21,505,416 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
increases expression |
ISO |
X |
21,498,202 |
21,505,416 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
multiple interactions |
ISO |
X |
21,498,202 |
21,505,416 |
RGD:6480464 |
CTD |
| G |
Dhx29 |
DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
|
multiple interactions |
ISO |
2 |
44,306,480 |
44,357,742 |
RGD:6480464 |
CTD |
| G |
Dhx29 |
DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
|
increases expression |
ISO |
2 |
44,306,480 |
44,357,742 |
RGD:6480464 |
CTD |
| G |
Dos |
downstream of Stk11 |
|
decreases expression |
EXP |
7 |
11,079,431 |
11,087,057 |
RGD:6480464 |
CTD |
| G |
Drosha |
drosha, ribonuclease type III |
|
affects expression |
ISO |
2 |
62,336,007 |
62,447,618 |
RGD:6480464 |
CTD |
| G |
Drosha |
drosha, ribonuclease type III |
|
multiple interactions |
ISO |
2 |
62,336,007 |
62,447,618 |
RGD:6480464 |
CTD |
| G |
Dtnbp1 |
dystrobrevin binding protein 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dtnbp1 |
dystrobrevin binding protein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dusp13 |
dual specificity phosphatase 13 |
|
multiple interactions |
ISO |
15 |
2,614,864 |
2,630,230 |
RGD:6480464 |
CTD |
| G |
Edc3 |
enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
affects expression |
ISO |
8 |
61,472,266 |
61,517,590 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
increases expression |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
multiple interactions |
ISO |
10 |
89,255,637 |
89,257,728 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
increases expression |
ISO |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
multiple interactions |
ISO |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Eif1l1 |
eukaryotic translation initiation factor 1-like 1 |
|
increases expression |
EXP |
5 |
21,736,137 |
21,736,478 |
RGD:6480464 |
CTD |
| G |
Epc1 |
enhancer of polycomb homolog 1 (Drosophila) |
|
affects expression |
ISO |
17 |
63,040,151 |
63,131,954 |
RGD:6480464 |
CTD |
| G |
Ext2 |
exostosin glycosyltransferase 2 |
|
increases expression |
ISO |
3 |
78,111,436 |
78,244,444 |
RGD:6480464 |
CTD |
| G |
Ext2 |
exostosin glycosyltransferase 2 |
|
multiple interactions |
ISO |
3 |
78,111,436 |
78,244,444 |
RGD:6480464 |
CTD |
| G |
Ext2 |
exostosin glycosyltransferase 2 |
|
affects expression |
ISO |
3 |
78,111,436 |
78,244,444 |
RGD:6480464 |
CTD |
| G |
Fbn2 |
fibrillin 2 |
|
decreases expression |
EXP |
18 |
53,883,011 |
53,914,001 |
RGD:6480464 |
CTD |
| G |
Fbxo18 |
F-box protein, helicase, 18 |
|
increases expression |
ISO |
17 |
77,945,025 |
77,982,314 |
RGD:6480464 |
CTD |
| G |
Fbxo18 |
F-box protein, helicase, 18 |
|
affects expression |
ISO |
17 |
77,945,025 |
77,982,314 |
RGD:6480464 |
CTD |
| G |
Fbxo18 |
F-box protein, helicase, 18 |
|
multiple interactions |
ISO |
17 |
77,945,025 |
77,982,314 |
RGD:6480464 |
CTD |
| G |
Fbxw7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
2 |
176,675,226 |
176,750,737 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Frg1 |
FSHD region gene 1 |
|
multiple interactions |
ISO |
16 |
54,237,736 |
54,259,311 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
affects expression |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
increases expression |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
multiple interactions |
ISO |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
|
multiple interactions |
ISO |
3 |
11,976,369 |
12,076,318 |
RGD:6480464 |
CTD |
| G |
Gdf1 |
growth differentiation factor 1 |
|
decreases expression |
EXP |
16 |
19,580,807 |
19,596,415 |
RGD:6480464 |
CTD |
| G |
Gpr39 |
G protein-coupled receptor 39 |
|
affects expression |
ISO |
13 |
38,181,953 |
38,400,282 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
decreases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Hbz |
hemoglobin, zeta |
|
multiple interactions |
ISO |
10 |
15,590,914 |
15,592,386 |
RGD:6480464 |
CTD |
| G |
Hbz |
hemoglobin, zeta |
|
increases expression |
ISO |
10 |
15,590,914 |
15,592,386 |
RGD:6480464 |
CTD |
| G |
Hist1h2bo |
histone cluster 1, H2bo |
|
affects expression |
ISO |
17 |
50,350,860 |
50,352,473 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
decreases expression |
EXP |
4 |
80,524,246 |
80,526,491 |
RGD:6480464 |
CTD |
| G |
Hspa14 |
heat shock protein 14 |
|
increases expression |
ISO |
17 |
85,848,593 |
85,869,375 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
affects expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hyi |
hydroxypyruvate isomerase |
|
affects expression |
ISO |
5 |
138,842,872 |
138,843,826 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
multiple interactions |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
increases expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
decreases expression |
EXP |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
EXP |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases secretion |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il27 |
interleukin 27 |
|
decreases expression |
EXP |
1 |
185,730,394 |
185,735,604 |
RGD:6480464 |
CTD |
| G |
Il3ra |
interleukin 3 receptor, alpha |
|
increases expression |
ISO |
12 |
16,825,702 |
16,830,035 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
affects expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
affects expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
affects expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Ilf2 |
interleukin enhancer binding factor 2 |
|
multiple interactions |
ISO |
2 |
182,741,739 |
182,761,593 |
RGD:6480464 |
CTD |
| G |
Ilf2 |
interleukin enhancer binding factor 2 |
|
increases expression |
ISO |
2 |
182,741,739 |
182,761,593 |
RGD:6480464 |
CTD |
| G |
Ipo11 |
importin 11 |
|
multiple interactions |
ISO |
2 |
38,006,409 |
38,054,430 |
RGD:6480464 |
CTD |
| G |
Ipo11 |
importin 11 |
|
increases expression |
ISO |
2 |
38,006,409 |
38,054,430 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon stimulated exonuclease gene 20 |
|
increases expression |
EXP |
1 |
134,631,524 |
134,637,868 |
RGD:6480464 |
CTD |
| G |
Isoc1 |
isochorismatase domain containing 1 |
|
increases expression |
EXP |
18 |
54,471,690 |
54,492,099 |
RGD:6480464 |
CTD |
| G |
Isoc2b |
isochorismatase domain containing 2b |
|
affects expression |
ISO |
1 |
67,689,184 |
67,710,260 |
RGD:6480464 |
CTD |
| G |
Isy1 |
ISY1 splicing factor homolog (S. cerevisiae) |
|
affects expression |
ISO |
4 |
122,006,785 |
122,027,475 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
increases expression |
ISO |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
increases expression |
EXP |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
affects expression |
EXP |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
increases expression |
EXP |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
affects expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
EXP |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itgb1bp1 |
integrin beta 1 binding protein 1 |
|
multiple interactions |
ISO |
6 |
41,830,110 |
41,844,514 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
multiple interactions |
ISO |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
increases expression |
EXP |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itgb7 |
integrin, beta 7 |
|
affects expression |
ISO |
7 |
140,971,310 |
140,984,091 |
RGD:6480464 |
CTD |
| G |
Itgb7 |
integrin, beta 7 |
|
increases expression |
ISO |
7 |
140,971,310 |
140,984,091 |
RGD:6480464 |
CTD |
| G |
Itgb7 |
integrin, beta 7 |
|
multiple interactions |
ISO |
7 |
140,971,310 |
140,984,091 |
RGD:6480464 |
CTD |
| G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
|
affects expression |
ISO |
16 |
6,341,043 |
6,358,767 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
increases expression |
ISO |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
multiple interactions |
ISO |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Itm2a |
integral membrane protein 2A |
|
decreases expression |
EXP |
X |
95,637,901 |
95,643,845 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
affects expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
increases expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
multiple interactions |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
decreases expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
decreases expression |
EXP |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2c |
integral membrane protein 2C |
|
multiple interactions |
ISO |
9 |
84,611,756 |
84,625,391 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
affects expression |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
decreases expression |
EXP |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
multiple interactions |
ISO |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
increases expression |
ISO |
13 |
66,228,241 |
66,235,533 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
affects expression |
ISO |
13 |
66,228,241 |
66,235,533 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
multiple interactions |
ISO |
13 |
66,228,241 |
66,235,533 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
decreases expression |
EXP |
3 |
125,181,063 |
125,216,481 |
RGD:6480464 |
CTD |
| G |
Jagn1 |
jagunal homolog 1 (Drosophila) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
decreases expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
affects expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
affects expression |
ISO |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
increases expression |
ISO |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
multiple interactions |
ISO |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kctd3 |
potassium channel tetramerisation domain containing 3 |
|
increases expression |
ISO |
13 |
105,117,483 |
105,155,705 |
RGD:6480464 |
CTD |
| G |
Kctd3 |
potassium channel tetramerisation domain containing 3 |
|
multiple interactions |
ISO |
13 |
105,117,483 |
105,155,705 |
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kifc3 |
kinesin family member C3 |
|
multiple interactions |
ISO |
19 |
10,335,789 |
10,354,364 |
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
EXP |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
increases expression |
ISO |
1 |
118,368,164 |
118,398,938 |
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
affects expression |
EXP |
4 |
124,714,395 |
124,726,991 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
multiple interactions |
ISO |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
decreases expression |
EXP |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
affects expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
affects expression |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
EXP |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
increases expression |
ISO |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
multiple interactions |
ISO |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
affects expression |
ISO |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
increases expression |
EXP |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klhdc2 |
kelch domain containing 2 |
|
affects expression |
ISO |
6 |
91,259,826 |
91,274,820 |
RGD:6480464 |
CTD |
| G |
Klhl10 |
kelch-like family member 10 |
|
affects expression |
ISO |
10 |
89,385,247 |
89,401,614 |
RGD:6480464 |
CTD |
| G |
Klhl11 |
kelch-like family member 11 |
|
multiple interactions |
ISO |
10 |
89,407,380 |
89,417,938 |
RGD:6480464 |
CTD |
| G |
Klhl11 |
kelch-like family member 11 |
|
affects expression |
ISO |
10 |
89,407,380 |
89,417,938 |
RGD:6480464 |
CTD |
| G |
Klhl11 |
kelch-like family member 11 |
|
increases expression |
ISO |
10 |
89,407,380 |
89,417,938 |
RGD:6480464 |
CTD |
| G |
Klhl14 |
kelch-like family member 14 |
|
affects expression |
ISO |
18 |
13,167,645 |
13,282,841 |
RGD:6480464 |
CTD |
| G |
Klhl28 |
kelch-like family member 28 |
|
multiple interactions |
ISO |
6 |
86,281,944 |
86,314,935 |
RGD:6480464 |
CTD |
| G |
Klhl29 |
kelch-like family member 29 |
|
multiple interactions |
ISO |
6 |
28,387,843 |
28,704,178 |
RGD:6480464 |
CTD |
| G |
Klhl29 |
kelch-like family member 29 |
|
increases expression |
ISO |
6 |
28,387,843 |
28,704,178 |
RGD:6480464 |
CTD |
| G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
|
decreases expression |
EXP |
1 |
94,380,646 |
94,384,705 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
affects expression |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
decreases expression |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
multiple interactions |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Klk9 |
kallikrein related-peptidase 9 |
|
affects expression |
ISO |
1 |
94,221,721 |
94,226,013 |
RGD:6480464 |
CTD |
| G |
Klk9 |
kallikrein related-peptidase 9 |
|
multiple interactions |
ISO |
1 |
94,221,721 |
94,226,013 |
RGD:6480464 |
CTD |
| G |
Klkb1 |
kallikrein B, plasma 1 |
|
affects expression |
ISO |
16 |
50,248,935 |
50,272,279 |
RGD:6480464 |
CTD |
| G |
Klrc2 |
killer cell lectin-like receptor subfamily C, member 2 |
|
affects expression |
EXP |
4 |
166,956,614 |
166,967,757 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
increases expression |
ISO |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
multiple interactions |
ISO |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
increases expression |
EXP |
10 |
85,882,382 |
85,910,805 |
RGD:6480464 |
CTD |
| G |
Kptn |
kaptin (actin binding protein) |
|
multiple interactions |
ISO |
1 |
76,460,104 |
76,460,898 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
affects expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
EXP |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
increases expression |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
increases expression |
EXP |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
increases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
increases expression |
EXP |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
multiple interactions |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
affects expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
increases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
affects expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Ktn1 |
kinectin 1 (kinesin receptor) |
|
multiple interactions |
ISO |
15 |
23,633,479 |
23,722,293 |
RGD:6480464 |
CTD |
| G |
Lace1 |
lactation elevated 1 |
|
multiple interactions |
ISO |
20 |
46,296,402 |
46,302,522 |
RGD:6480464 |
CTD |
| G |
Leng1 |
leukocyte receptor cluster (LRC) member 1 |
|
increases expression |
ISO |
1 |
63,864,911 |
63,869,843 |
RGD:6480464 |
CTD |
| G |
Leng1 |
leukocyte receptor cluster (LRC) member 1 |
|
multiple interactions |
ISO |
1 |
63,864,911 |
63,869,843 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
decreases expression |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Leprel2 |
leprecan-like 2 |
|
decreases expression |
EXP |
4 |
160,964,297 |
160,978,321 |
RGD:6480464 |
CTD |
| G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
|
affects expression |
ISO |
14 |
82,637,839 |
82,677,419 |
RGD:6480464 |
CTD |
| G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
|
increases expression |
ISO |
14 |
82,637,839 |
82,677,419 |
RGD:6480464 |
CTD |
| G |
Letm1 |
leucine zipper-EF-hand containing transmembrane protein 1 |
|
multiple interactions |
ISO |
14 |
82,637,839 |
82,677,419 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
affects expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
increases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
multiple interactions |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
decreases expression |
EXP |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression |
EXP |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lgals5 |
lectin, galactose binding, soluble 5 |
|
increases expression |
EXP |
10 |
65,075,525 |
65,078,686 |
RGD:6480464 |
CTD |
| G |
Lgals7 |
lectin, galactoside-binding, soluble, 7 |
|
increases expression |
ISO |
1 |
83,968,263 |
83,970,018 |
RGD:6480464 |
CTD |
| G |
Lgals9 |
lectin, galactoside-binding, soluble, 9 |
|
increases expression |
EXP |
10 |
65,129,006 |
65,152,052 |
RGD:6480464 |
CTD |
| G |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
|
decreases expression |
EXP |
3 |
95,370,049 |
95,471,040 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
|
increases expression |
ISO |
2 |
24,407,387 |
24,489,407 |
RGD:6480464 |
CTD |
| G |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
|
multiple interactions |
ISO |
2 |
24,407,387 |
24,489,407 |
RGD:6480464 |
CTD |
| G |
Lias |
lipoic acid synthetase |
|
multiple interactions |
ISO |
14 |
45,575,334 |
45,592,514 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
affects expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
multiple interactions |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
increases expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
affects expression |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
multiple interactions |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
increases expression |
ISO |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
multiple interactions |
ISO |
10 |
71,000,287 |
71,021,398 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
affects expression |
ISO |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
increases expression |
ISO |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
multiple interactions |
ISO |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Limk2 |
LIM domain kinase 2 |
|
affects expression |
ISO |
14 |
83,969,282 |
84,037,218 |
RGD:6480464 |
CTD |
| G |
Limk2 |
LIM domain kinase 2 |
|
affects expression |
EXP |
14 |
83,969,282 |
84,037,218 |
RGD:6480464 |
CTD |
| G |
Limk2 |
LIM domain kinase 2 |
|
decreases expression |
EXP |
14 |
83,969,282 |
84,037,218 |
RGD:6480464 |
CTD |
| G |
Lin37 |
lin-37 homolog (C. elegans) |
|
affects expression |
ISO |
1 |
85,601,215 |
85,605,147 |
RGD:6480464 |
CTD |
| G |
Lin7b |
lin-7 homolog b (C. elegans) |
|
affects expression |
ISO |
1 |
95,838,781 |
95,841,356 |
RGD:6480464 |
CTD |
| G |
Lin7b |
lin-7 homolog b (C. elegans) |
|
increases expression |
ISO |
1 |
95,838,781 |
95,841,356 |
RGD:6480464 |
CTD |
| G |
Lin7b |
lin-7 homolog b (C. elegans) |
|
multiple interactions |
ISO |
1 |
95,838,781 |
95,841,356 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
decreases expression |
ISO |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lipf |
lipase, gastric |
|
increases expression |
EXP |
1 |
237,838,238 |
237,856,579 |
RGD:6480464 |
CTD |
| G |
Litaf |
lipopolysaccharide-induced TNF factor |
|
increases expression |
EXP |
10 |
4,614,177 |
4,623,903 |
RGD:6480464 |
CTD |
| G |
LOC100360113 |
mortality factor 4 like 1-like |
|
multiple interactions |
ISO |
8 |
95,006,476 |
95,027,439 |
RGD:6480464 |
CTD |
| G |
LOC100360260 |
chromobox homolog 3-like |
|
decreases expression |
EXP |
16 |
32,507,709 |
32,508,260 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
increases expression |
ISO |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
multiple interactions |
ISO |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
LOC686736 |
similar to H3 histone, family 3B |
|
increases expression |
ISO |
1 |
212,798,225 |
212,798,635 |
RGD:6480464 |
CTD |
| G |
LOC686736 |
similar to H3 histone, family 3B |
|
multiple interactions |
ISO |
1 |
212,798,225 |
212,798,635 |
RGD:6480464 |
CTD |
| G |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
|
increases expression |
ISO |
9 |
90,278,891 |
90,346,980 |
RGD:6480464 |
CTD |
| G |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
|
multiple interactions |
ISO |
9 |
90,278,891 |
90,346,980 |
RGD:6480464 |
CTD |
| G |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
|
affects expression |
ISO |
8 |
115,509,800 |
115,612,552 |
RGD:6480464 |
CTD |
| G |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
|
multiple interactions |
ISO |
8 |
115,509,800 |
115,612,552 |
RGD:6480464 |
CTD |
| G |
Lsamp |
limbic system-associated membrane protein |
|
decreases expression |
EXP |
11 |
60,170,406 |
60,870,875 |
RGD:6480464 |
CTD |
| G |
Lsm10 |
LSM10, U7 small nuclear RNA associated |
|
multiple interactions |
ISO |
5 |
145,450,575 |
145,452,403 |
RGD:6480464 |
CTD |
| G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
|
increases expression |
ISO |
16 |
19,261,065 |
19,266,484 |
RGD:6480464 |
CTD |
| G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
|
multiple interactions |
ISO |
16 |
19,261,065 |
19,266,484 |
RGD:6480464 |
CTD |
| G |
Lsp1 |
lymphocyte-specific protein 1 |
|
decreases expression |
EXP |
1 |
202,707,305 |
202,741,026 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
EXP |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin beta (TNF superfamily, member 3) |
|
multiple interactions |
ISO |
20 |
3,666,524 |
3,668,369 |
RGD:6480464 |
CTD |
| G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
|
increases expression |
EXP |
6 |
19,942,626 |
20,355,084 |
RGD:6480464 |
CTD |
| G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
|
increases expression |
EXP |
6 |
108,826,446 |
108,924,746 |
RGD:6480464 |
CTD |
| G |
Ltbp3 |
latent transforming growth factor beta binding protein 3 |
|
decreases expression |
EXP |
1 |
208,369,474 |
208,385,572 |
RGD:6480464 |
CTD |
| G |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
|
multiple interactions |
ISO |
1 |
82,385,953 |
82,418,177 |
RGD:6480464 |
CTD |
| G |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
|
decreases expression |
EXP |
1 |
82,385,953 |
82,418,177 |
RGD:6480464 |
CTD |
| G |
Ltbr |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
|
affects expression |
EXP |
4 |
161,431,864 |
161,438,265 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
affects expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
multiple interactions |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
affects expression |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
increases expression |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
multiple interactions |
ISO |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
decreases expression |
EXP |
7 |
35,083,480 |
35,090,284 |
RGD:6480464 |
CTD |
| G |
Lxn |
latexin |
|
multiple interactions |
ISO |
2 |
157,310,036 |
157,315,905 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
affects expression |
ISO |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
increases expression |
ISO |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
increases expression |
EXP |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
multiple interactions |
ISO |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Ly6g6c |
lymphocyte antigen 6 complex, locus G6C |
|
increases expression |
ISO |
20 |
3,817,976 |
3,820,673 |
RGD:6480464 |
CTD |
| G |
Ly6g6c |
lymphocyte antigen 6 complex, locus G6C |
|
multiple interactions |
ISO |
20 |
3,817,976 |
3,820,673 |
RGD:6480464 |
CTD |
| G |
Ly6i |
lymphocyte antigen 6 complex, locus I |
|
increases expression |
EXP |
7 |
113,306,011 |
113,310,996 |
RGD:6480464 |
CTD |
| G |
Ly86 |
lymphocyte antigen 86 |
|
increases expression |
ISO |
17 |
33,667,680 |
33,768,108 |
RGD:6480464 |
CTD |
| G |
Lyar |
Ly1 antibody reactive |
|
multiple interactions |
ISO |
14 |
77,859,637 |
77,873,205 |
RGD:6480464 |
CTD |
| G |
Lyar |
Ly1 antibody reactive |
|
increases expression |
ISO |
14 |
77,859,637 |
77,873,205 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lynx1 |
Ly6/neurotoxin 1 |
|
multiple interactions |
ISO |
7 |
112,862,566 |
112,867,769 |
RGD:6480464 |
CTD |
| G |
Lypd1 |
Ly6/Plaur domain containing 1 |
|
affects expression |
ISO |
13 |
38,399,429 |
38,441,498 |
RGD:6480464 |
CTD |
| G |
Lypd1 |
Ly6/Plaur domain containing 1 |
|
multiple interactions |
ISO |
13 |
38,399,429 |
38,441,498 |
RGD:6480464 |
CTD |
| G |
Lyrm5 |
LYR motif containing 5 |
|
affects expression |
ISO |
4 |
182,859,926 |
182,865,036 |
RGD:6480464 |
CTD |
| G |
Macf1 |
microtubule-actin crosslinking factor 1 |
|
affects expression |
ISO |
5 |
142,659,726 |
142,986,873 |
RGD:6480464 |
CTD |
| G |
Macf1 |
microtubule-actin crosslinking factor 1 |
|
increases expression |
ISO |
5 |
142,659,726 |
142,986,873 |
RGD:6480464 |
CTD |
| G |
Macf1 |
microtubule-actin crosslinking factor 1 |
|
multiple interactions |
ISO |
5 |
142,659,726 |
142,986,873 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions |
ISO |
17 |
61,910,179 |
61,930,459 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
|
multiple interactions |
ISO |
1 |
84,094,589 |
84,116,015 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
affects expression |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen activated protein kinase 13 |
|
increases expression |
ISO |
20 |
7,055,313 |
7,064,405 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen activated protein kinase 13 |
|
increases expression |
EXP |
20 |
7,055,313 |
7,064,405 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
affects expression |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
affects expression |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
increases expression |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
increases expression |
ISO |
10 |
14,147,895 |
14,186,277 |
RGD:6480464 |
CTD |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
multiple interactions |
ISO |
10 |
14,147,895 |
14,186,277 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
|
increases expression |
EXP |
8 |
112,497,626 |
112,531,778 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
affects expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
March10 |
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
|
affects expression |
ISO |
10 |
94,762,789 |
94,855,777 |
RGD:6480464 |
CTD |
| G |
March5 |
membrane-associated ring finger (C3HC4) 5 |
|
increases expression |
ISO |
1 |
241,475,394 |
241,495,500 |
RGD:6480464 |
CTD |
| G |
March5 |
membrane-associated ring finger (C3HC4) 5 |
|
multiple interactions |
ISO |
1 |
241,475,394 |
241,495,500 |
RGD:6480464 |
CTD |
| G |
March7 |
membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
3 |
41,922,568 |
41,954,630 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
affects expression |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
multiple interactions |
ISO |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Marco |
macrophage receptor with collagenous structure |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mark1 |
MAP/microtubule affinity-regulating kinase 1 |
|
multiple interactions |
ISO |
13 |
100,905,369 |
101,009,161 |
RGD:6480464 |
CTD |
| G |
Mark2 |
MAP/microtubule affinity-regulating kinase 2 |
|
increases expression |
ISO |
1 |
209,958,902 |
210,022,099 |
RGD:6480464 |
CTD |
| G |
Mark2 |
MAP/microtubule affinity-regulating kinase 2 |
|
multiple interactions |
ISO |
1 |
209,958,902 |
210,022,099 |
RGD:6480464 |
CTD |
| G |
Mark3 |
MAP/microtubule affinity-regulating kinase 3 |
|
multiple interactions |
ISO |
6 |
136,348,832 |
136,438,667 |
RGD:6480464 |
CTD |
| G |
Mark3 |
MAP/microtubule affinity-regulating kinase 3 |
|
increases expression |
ISO |
6 |
136,348,832 |
136,438,667 |
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
decreases expression |
EXP |
11 |
79,532,504 |
79,602,755 |
RGD:6480464 |
CTD |
| G |
MAST1 |
microtubule associated serine/threonine kinase 1 |
|
increases expression |
ISO |
19 |
24,872,709 |
24,900,429 |
RGD:6480464 |
CTD |
| G |
MAST1 |
microtubule associated serine/threonine kinase 1 |
|
multiple interactions |
ISO |
19 |
24,872,709 |
24,900,429 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
|
decreases expression |
ISO |
15 |
105,356,456 |
105,514,135 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
|
multiple interactions |
ISO |
15 |
105,356,456 |
105,514,135 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
|
increases expression |
EXP |
15 |
105,356,456 |
105,514,135 |
RGD:6480464 |
CTD |
| G |
Mdn1 |
midasin homolog (yeast) |
|
affects expression |
ISO |
5 |
48,961,431 |
49,082,520 |
RGD:6480464 |
CTD |
| G |
Mdn1 |
midasin homolog (yeast) |
|
multiple interactions |
ISO |
5 |
48,961,431 |
49,082,520 |
RGD:6480464 |
CTD |
| G |
Megf6 |
multiple EGF-like-domains 6 |
|
increases expression |
ISO |
5 |
171,022,566 |
171,050,436 |
RGD:6480464 |
CTD |
| G |
Megf6 |
multiple EGF-like-domains 6 |
|
multiple interactions |
ISO |
5 |
171,022,566 |
171,050,436 |
RGD:6480464 |
CTD |
| G |
Meig1 |
meiosis expressed gene 1 |
|
affects expression |
ISO |
17 |
85,934,114 |
85,946,695 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
affects expression |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
decreases expression |
EXP |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
increases expression |
ISO |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
affects expression |
EXP |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
multiple interactions |
ISO |
5 |
60,787,123 |
60,848,620 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
affects expression |
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
increases expression |
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia I |
|
multiple interactions |
ISO |
1 |
209,114,987 |
209,120,837 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
multiple interactions |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Mesp2 |
mesoderm posterior 2 homolog (mouse) |
|
affects expression |
ISO |
1 |
135,590,020 |
135,592,626 |
RGD:6480464 |
CTD |
| G |
Mesp2 |
mesoderm posterior 2 homolog (mouse) |
|
increases expression |
ISO |
1 |
135,590,020 |
135,592,626 |
RGD:6480464 |
CTD |
| G |
Mesp2 |
mesoderm posterior 2 homolog (mouse) |
|
multiple interactions |
ISO |
1 |
135,590,020 |
135,592,626 |
RGD:6480464 |
CTD |
| G |
Mest |
mesoderm specific transcript homolog (mouse) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
|
increases expression |
ISO |
3 |
53,758,752 |
53,832,869 |
RGD:6480464 |
CTD |
| G |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
|
multiple interactions |
ISO |
3 |
53,758,752 |
53,832,869 |
RGD:6480464 |
CTD |
| G |
Metap2 |
methionyl aminopeptidase 2 |
|
increases expression |
ISO |
7 |
30,974,071 |
31,001,641 |
RGD:6480464 |
CTD |
| G |
Metap2 |
methionyl aminopeptidase 2 |
|
multiple interactions |
ISO |
7 |
30,974,071 |
31,001,641 |
RGD:6480464 |
CTD |
| G |
Mettl16 |
methyltransferase like 16 |
|
affects expression |
EXP |
10 |
62,087,541 |
62,134,061 |
RGD:6480464 |
CTD |
| G |
Mettl7a |
methyltransferase like 7A |
|
affects expression |
ISO |
7 |
139,062,222 |
139,062,833 |
RGD:6480464 |
CTD |
| G |
Mfap2 |
microfibrillar-associated protein 2 |
|
affects expression |
ISO |
5 |
159,868,933 |
159,874,481 |
RGD:6480464 |
CTD |
| G |
Mfap2 |
microfibrillar-associated protein 2 |
|
multiple interactions |
ISO |
5 |
159,868,933 |
159,874,481 |
RGD:6480464 |
CTD |
| G |
Mfap3 |
microfibrillar-associated protein 3 |
|
affects expression |
ISO |
10 |
43,106,313 |
43,118,827 |
RGD:6480464 |
CTD |
| G |
Mfap3 |
microfibrillar-associated protein 3 |
|
multiple interactions |
ISO |
10 |
43,106,313 |
43,118,827 |
RGD:6480464 |
CTD |
| G |
Mfap3 |
microfibrillar-associated protein 3 |
|
increases expression |
ISO |
10 |
43,106,313 |
43,118,827 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
increases expression |
ISO |
10 |
47,646,157 |
47,649,095 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
multiple interactions |
ISO |
10 |
47,646,157 |
47,649,095 |
RGD:6480464 |
CTD |
| G |
Mff |
mitochondrial fission factor |
|
affects expression |
ISO |
9 |
82,045,236 |
82,071,135 |
RGD:6480464 |
CTD |
| G |
Mgat1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
affects expression |
ISO |
10 |
34,706,908 |
34,724,328 |
RGD:6480464 |
CTD |
| G |
Mgat1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
10 |
34,706,908 |
34,724,328 |
RGD:6480464 |
CTD |
| G |
Mgat1 |
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
multiple interactions |
ISO |
10 |
34,706,908 |
34,724,328 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
multiple interactions |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
affects expression |
ISO |
1 |
250,966,386 |
251,000,363 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
increases expression |
ISO |
1 |
250,966,386 |
251,000,363 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
multiple interactions |
ISO |
1 |
250,966,386 |
251,000,363 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
increases expression |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
multiple interactions |
ISO |
4 |
122,822,493 |
122,922,892 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
decreases expression |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
decreases expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
affects expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mib2 |
mindbomb E3 ubiquitin protein ligase 2 |
|
decreases expression |
ISO |
5 |
172,490,963 |
172,497,379 |
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mlxipl |
MLX interacting protein-like |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mppe1 |
metallophosphoesterase 1 |
|
multiple interactions |
ISO |
18 |
63,738,125 |
63,756,486 |
RGD:6480464 |
CTD |
| G |
Mpv17 |
MpV17 mitochondrial inner membrane protein |
|
multiple interactions |
ISO |
6 |
25,200,452 |
25,214,909 |
RGD:6480464 |
CTD |
| G |
Mpv17l |
MPV17 mitochondrial membrane protein-like |
|
multiple interactions |
ISO |
10 |
1,655,565 |
1,672,677 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
decreases expression |
EXP |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
increases expression |
EXP |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
multiple interactions |
ISO |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Mrc1 |
mannose receptor, C type 1 |
|
increases expression |
ISO |
17 |
88,411,265 |
88,492,622 |
RGD:6480464 |
CTD |
| G |
Mrc1 |
mannose receptor, C type 1 |
|
multiple interactions |
ISO |
17 |
88,411,265 |
88,492,622 |
RGD:6480464 |
CTD |
| G |
Mrp63 |
mitochondrial ribosomal protein 63 |
|
affects expression |
ISO |
15 |
36,866,920 |
36,867,782 |
RGD:6480464 |
CTD |
| G |
mrpl11 |
mitochondrial ribosomal protein L11 |
|
increases expression |
ISO |
1 |
207,580,240 |
207,583,065 |
RGD:6480464 |
CTD |
| G |
mrpl11 |
mitochondrial ribosomal protein L11 |
|
multiple interactions |
ISO |
1 |
207,580,240 |
207,583,065 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
increases expression |
ISO |
10 |
109,870,160 |
109,874,664 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
multiple interactions |
ISO |
10 |
109,870,160 |
109,874,664 |
RGD:6480464 |
CTD |
| G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
|
affects expression |
ISO |
7 |
92,047,293 |
92,068,851 |
RGD:6480464 |
CTD |
| G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
|
increases expression |
ISO |
7 |
92,047,293 |
92,068,851 |
RGD:6480464 |
CTD |
| G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
|
multiple interactions |
ISO |
7 |
92,047,293 |
92,068,851 |
RGD:6480464 |
CTD |
| G |
Mrpl13 |
mitochondrial ribosomal protein L13 |
|
affects expression |
EXP |
7 |
92,047,293 |
92,068,851 |
RGD:6480464 |
CTD |
| G |
Mrpl15 |
mitochondrial ribosomal protein L15 |
|
increases expression |
ISO |
5 |
14,932,623 |
14,943,904 |
RGD:6480464 |
CTD |
| G |
Mrpl15 |
mitochondrial ribosomal protein L15 |
|
multiple interactions |
ISO |
5 |
14,932,623 |
14,943,904 |
RGD:6480464 |
CTD |
| G |
Mrpl17 |
mitochondrial ribosomal protein L17 |
|
affects expression |
ISO |
1 |
163,554,720 |
163,556,294 |
RGD:6480464 |
CTD |
| G |
Mrpl17 |
mitochondrial ribosomal protein L17 |
|
increases expression |
ISO |
1 |
163,554,720 |
163,556,294 |
RGD:6480464 |
CTD |
| G |
Mrpl17 |
mitochondrial ribosomal protein L17 |
|
multiple interactions |
ISO |
1 |
163,554,720 |
163,556,294 |
RGD:6480464 |
CTD |
| G |
Mrpl18 |
mitochondrial ribosomal protein L18 |
|
affects expression |
ISO |
1 |
42,111,647 |
42,116,465 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
multiple interactions |
ISO |
4 |
116,207,542 |
116,211,771 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
increases expression |
ISO |
4 |
116,207,542 |
116,211,771 |
RGD:6480464 |
CTD |
| G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
|
increases expression |
ISO |
9 |
10,016,260 |
10,020,033 |
RGD:6480464 |
CTD |
| G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
|
multiple interactions |
ISO |
9 |
10,016,260 |
10,020,033 |
RGD:6480464 |
CTD |
| G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
|
affects expression |
ISO |
9 |
10,016,260 |
10,020,033 |
RGD:6480464 |
CTD |
| G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
|
increases expression |
ISO |
5 |
172,657,923 |
172,662,453 |
RGD:6480464 |
CTD |
| G |
mrpl24 |
mitochondrial ribosomal protein L24 |
|
affects expression |
ISO |
2 |
179,995,713 |
180,001,745 |
RGD:6480464 |
CTD |
| G |
Mrpl28 |
mitochondrial ribosomal protein L28 |
|
multiple interactions |
ISO |
10 |
15,394,360 |
15,397,270 |
RGD:6480464 |
CTD |
| G |
Mrpl28 |
mitochondrial ribosomal protein L28 |
|
increases expression |
ISO |
10 |
15,394,360 |
15,397,270 |
RGD:6480464 |
CTD |
| G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
|
affects expression |
ISO |
8 |
110,130,050 |
110,153,411 |
RGD:6480464 |
CTD |
| G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
|
increases expression |
ISO |
8 |
110,130,050 |
110,153,411 |
RGD:6480464 |
CTD |
| G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
|
multiple interactions |
ISO |
8 |
110,130,050 |
110,153,411 |
RGD:6480464 |
CTD |
| G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
|
multiple interactions |
ISO |
6 |
24,870,269 |
24,878,462 |
RGD:6480464 |
CTD |
| G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
|
multiple interactions |
ISO |
6 |
24,870,269 |
24,878,462 |
RGD:6480464 |
CTD |
| G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
|
increases expression |
ISO |
4 |
105,103,325 |
105,111,093 |
RGD:6480464 |
CTD |
| G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
|
multiple interactions |
ISO |
4 |
105,103,325 |
105,111,093 |
RGD:6480464 |
CTD |
| G |
Mrpl36 |
mitochondrial ribosomal protein L36 |
|
multiple interactions |
ISO |
17 |
41,265 |
42,361 |
RGD:6480464 |
CTD |
| G |
Mrpl37 |
mitochondrial ribosomal protein L37 |
|
affects expression |
ISO |
5 |
128,135,417 |
128,145,916 |
RGD:6480464 |
CTD |
| G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
|
increases expression |
ISO |
8 |
20,026,103 |
20,032,118 |
RGD:6480464 |
CTD |
| G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
|
multiple interactions |
ISO |
8 |
20,026,103 |
20,032,118 |
RGD:6480464 |
CTD |
| G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
|
increases expression |
ISO |
10 |
86,046,541 |
86,058,364 |
RGD:6480464 |
CTD |
| G |
Mrpl45 |
mitochondrial ribosomal protein L45 |
|
multiple interactions |
ISO |
10 |
86,046,541 |
86,058,364 |
RGD:6480464 |
CTD |
| G |
Mrpl48 |
mitochondrial ribosomal protein L48 |
|
decreases expression |
EXP |
1 |
157,979,818 |
158,022,405 |
RGD:6480464 |
CTD |
| G |
Mrpl49 |
mitochondrial ribosomal protein L49 |
|
increases expression |
ISO |
1 |
208,692,089 |
208,694,868 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
multiple interactions |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Mthfd1l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
affects expression |
ISO |
1 |
34,759,445 |
34,800,865 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
increases expression |
ISO |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
multiple interactions |
ISO |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Mthfs |
5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) |
|
multiple interactions |
ISO |
8 |
94,058,605 |
94,108,277 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
affects expression |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases expression |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtss1 |
metastasis suppressor 1 |
|
affects expression |
ISO |
7 |
95,808,266 |
95,947,927 |
RGD:6480464 |
CTD |
| G |
Mtss1 |
metastasis suppressor 1 |
|
increases expression |
ISO |
7 |
95,808,266 |
95,947,927 |
RGD:6480464 |
CTD |
| G |
Mtss1 |
metastasis suppressor 1 |
|
multiple interactions |
ISO |
7 |
95,808,266 |
95,947,927 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
microtubule associated tumor suppressor 1 |
|
increases expression |
EXP |
16 |
54,611,502 |
54,664,075 |
RGD:6480464 |
CTD |
| G |
Mtx1 |
Metaxin 1 |
|
affects expression |
ISO |
2 |
181,379,690 |
181,381,406 |
RGD:6480464 |
CTD |
| G |
Mtx1 |
Metaxin 1 |
|
decreases expression |
ISO |
2 |
181,379,690 |
181,381,406 |
RGD:6480464 |
CTD |
| G |
Mtx1 |
Metaxin 1 |
|
multiple interactions |
ISO |
2 |
181,379,690 |
181,381,406 |
RGD:6480464 |
CTD |
| G |
Mtx2 |
metaxin 2 |
|
multiple interactions |
ISO |
3 |
57,460,900 |
57,523,379 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
affects expression |
EXP |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
increases expression |
EXP |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
increases expression |
EXP |
11 |
69,830,276 |
69,858,366 |
RGD:6480464 |
CTD |
| G |
Mup1 |
major urinary protein 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mup1 |
major urinary protein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mus81 |
MUS81 structure-specific endonuclease |
|
multiple interactions |
ISO |
1 |
208,126,545 |
208,131,820 |
RGD:6480464 |
CTD |
| G |
Mut |
methylmalonyl CoA mutase |
|
increases expression |
ISO |
9 |
16,065,495 |
16,093,956 |
RGD:6480464 |
CTD |
| G |
Mut |
methylmalonyl CoA mutase |
|
multiple interactions |
ISO |
9 |
16,065,495 |
16,093,956 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
increases expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
affects expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
multiple interactions |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
affects expression |
EXP |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
increases expression |
EXP |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
multiple interactions |
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
increases expression |
EXP |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Mxd3 |
Max dimerization protein 3 |
|
affects expression |
EXP |
17 |
15,346,165 |
15,349,891 |
RGD:6480464 |
CTD |
| G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
affects expression |
ISO |
1 |
259,219,584 |
259,259,979 |
RGD:6480464 |
CTD |
| G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
increases expression |
ISO |
1 |
259,219,584 |
259,259,979 |
RGD:6480464 |
CTD |
| G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
multiple interactions |
ISO |
1 |
259,219,584 |
259,259,979 |
RGD:6480464 |
CTD |
| G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
decreases expression |
EXP |
1 |
259,219,584 |
259,259,979 |
RGD:6480464 |
CTD |
| G |
Mxra8 |
matrix-remodelling associated 8 |
|
decreases expression |
EXP |
5 |
172,698,249 |
172,702,599 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
increases expression |
ISO |
3 |
153,925,908 |
153,954,323 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
multiple interactions |
ISO |
3 |
153,925,908 |
153,954,323 |
RGD:6480464 |
CTD |
| G |
Mybpc2 |
myosin binding protein C, fast-type |
|
affects expression |
ISO |
1 |
94,979,308 |
95,002,804 |
RGD:6480464 |
CTD |
| G |
Mybpc2 |
myosin binding protein C, fast-type |
|
multiple interactions |
ISO |
1 |
94,979,308 |
95,002,804 |
RGD:6480464 |
CTD |
| G |
Mybpc2 |
myosin binding protein C, fast-type |
|
increases expression |
ISO |
1 |
94,979,308 |
95,002,804 |
RGD:6480464 |
CTD |
| G |
Mybph |
myosin binding protein H |
|
affects expression |
ISO |
13 |
47,151,091 |
47,158,665 |
RGD:6480464 |
CTD |
| G |
Mybph |
myosin binding protein H |
|
multiple interactions |
ISO |
13 |
47,151,091 |
47,158,665 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
affects expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Mycbp |
c-myc binding protein |
|
increases expression |
ISO |
5 |
143,196,136 |
143,203,083 |
RGD:6480464 |
CTD |
| G |
Mycbp |
c-myc binding protein |
|
multiple interactions |
ISO |
5 |
143,196,136 |
143,203,083 |
RGD:6480464 |
CTD |
| G |
Mycbpap |
Mycbp associated protein |
|
multiple interactions |
ISO |
10 |
83,140,371 |
83,143,078 |
RGD:6480464 |
CTD |
| G |
Ncbp2 |
nuclear cap binding protein subunit 2 |
|
multiple interactions |
ISO |
11 |
70,642,907 |
70,651,744 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
increases expression |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Ncf4 |
neutrophil cytosolic factor 4 |
|
affects expression |
ISO |
7 |
116,167,621 |
116,190,630 |
RGD:6480464 |
CTD |
| G |
Ncf4 |
neutrophil cytosolic factor 4 |
|
multiple interactions |
ISO |
7 |
116,167,621 |
116,190,630 |
RGD:6480464 |
CTD |
| G |
Ncf4 |
neutrophil cytosolic factor 4 |
|
increases expression |
ISO |
7 |
116,167,621 |
116,190,630 |
RGD:6480464 |
CTD |
| G |
Ncf4 |
neutrophil cytosolic factor 4 |
|
increases expression |
EXP |
7 |
116,167,621 |
116,190,630 |
RGD:6480464 |
CTD |
| G |
Nckap1l |
NCK associated protein 1 like |
|
multiple interactions |
ISO |
7 |
142,351,954 |
142,397,045 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
decreases expression |
EXP |
9 |
85,112,752 |
85,121,276 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
increases expression |
EXP |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa4 |
nuclear receptor coactivator 4 |
|
affects expression |
ISO |
16 |
7,642,116 |
7,662,460 |
RGD:6480464 |
CTD |
| G |
Ncoa4 |
nuclear receptor coactivator 4 |
|
multiple interactions |
ISO |
16 |
7,642,116 |
7,662,460 |
RGD:6480464 |
CTD |
| G |
Ncoa4 |
nuclear receptor coactivator 4 |
|
increases expression |
ISO |
16 |
7,642,116 |
7,662,460 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
ISO |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
affects expression |
EXP |
12 |
32,617,643 |
32,725,753 |
RGD:6480464 |
CTD |
| G |
Ndn |
necdin, melanoma antigen (MAGE) family member |
|
decreases expression |
EXP |
1 |
116,594,603 |
116,596,202 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
affects expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
multiple interactions |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
EXP |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
affects expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
increases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
affects expression |
EXP |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
multiple interactions |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
affects expression |
ISO |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
decreases expression |
EXP |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
increases expression |
EXP |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndst2 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
|
increases expression |
ISO |
15 |
3,788,239 |
3,798,682 |
RGD:6480464 |
CTD |
| G |
Ndst2 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
|
multiple interactions |
ISO |
15 |
3,788,239 |
3,798,682 |
RGD:6480464 |
CTD |
| G |
Ndufa1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 |
|
increases expression |
ISO |
X |
7,726,163 |
7,730,110 |
RGD:6480464 |
CTD |
| G |
Ndufa1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 |
|
multiple interactions |
ISO |
X |
7,726,163 |
7,730,110 |
RGD:6480464 |
CTD |
| G |
Ndufa10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 |
|
multiple interactions |
ISO |
9 |
91,655,135 |
91,689,653 |
RGD:6480464 |
CTD |
| G |
Ndufa10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 |
|
increases expression |
ISO |
9 |
91,655,135 |
91,689,653 |
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
affects expression |
ISO |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
multiple interactions |
ISO |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
decreases expression |
EXP |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufa8 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 |
|
multiple interactions |
ISO |
3 |
15,146,311 |
15,159,529 |
RGD:6480464 |
CTD |
| G |
Ndufa8 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 |
|
increases expression |
ISO |
3 |
15,146,311 |
15,159,529 |
RGD:6480464 |
CTD |
| G |
Ndufa9 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 |
|
increases expression |
ISO |
4 |
163,208,781 |
163,237,542 |
RGD:6480464 |
CTD |
| G |
Ndufa9 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 |
|
multiple interactions |
ISO |
4 |
163,208,781 |
163,237,542 |
RGD:6480464 |
CTD |
| G |
Ndufab1 |
NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 |
|
increases expression |
EXP |
1 |
180,908,331 |
180,921,734 |
RGD:6480464 |
CTD |
| G |
Ndufb2 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 |
|
multiple interactions |
ISO |
4 |
67,099,841 |
67,106,920 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
increases expression |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
multiple interactions |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufb7 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 |
|
increases expression |
ISO |
19 |
26,259,362 |
26,263,700 |
RGD:6480464 |
CTD |
| G |
Ndufb7 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 |
|
multiple interactions |
ISO |
19 |
26,259,362 |
26,263,700 |
RGD:6480464 |
CTD |
| G |
Ndufb8 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 |
|
increases expression |
ISO |
1 |
249,597,402 |
249,602,443 |
RGD:6480464 |
CTD |
| G |
Ndufb8 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 |
|
multiple interactions |
ISO |
1 |
249,597,402 |
249,602,443 |
RGD:6480464 |
CTD |
| G |
Ndufb9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 |
|
increases expression |
ISO |
7 |
95,949,322 |
95,955,668 |
RGD:6480464 |
CTD |
| G |
Nek9 |
NIMA-related kinase 9 |
|
increases expression |
EXP |
6 |
109,345,437 |
109,389,174 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
increases expression |
ISO |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
decreases expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Ngp |
neutrophilic granule protein |
|
multiple interactions |
ISO |
8 |
114,795,567 |
114,798,934 |
RGD:6480464 |
CTD |
| G |
Ngp |
neutrophilic granule protein |
|
increases expression |
ISO |
8 |
114,795,567 |
114,798,934 |
RGD:6480464 |
CTD |
| G |
Nhsl1 |
NHS-like 1 |
|
multiple interactions |
ISO |
1 |
13,479,076 |
13,620,447 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
increases expression |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
affects expression |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
multiple interactions |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
decreases expression |
EXP |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
multiple interactions |
ISO |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nipsnap1 |
nipsnap homolog 1 (C. elegans) |
|
decreases expression |
EXP |
14 |
85,532,437 |
85,556,559 |
RGD:6480464 |
CTD |
| G |
Nipsnap3a |
nipsnap homolog 3A (C. elegans) |
|
increases expression |
EXP |
5 |
70,425,039 |
70,435,740 |
RGD:6480464 |
CTD |
| G |
Nkiras1 |
NFKB inhibitor interacting Ras-like 1 |
|
increases expression |
ISO |
15 |
9,072,535 |
9,082,065 |
RGD:6480464 |
CTD |
| G |
Nkiras1 |
NFKB inhibitor interacting Ras-like 1 |
|
multiple interactions |
ISO |
15 |
9,072,535 |
9,082,065 |
RGD:6480464 |
CTD |
| G |
Nkiras2 |
NFKB inhibitor interacting Ras-like 2 |
|
affects expression |
ISO |
10 |
89,567,630 |
89,571,657 |
RGD:6480464 |
CTD |
| G |
Nkiras2 |
NFKB inhibitor interacting Ras-like 2 |
|
increases expression |
ISO |
10 |
89,567,630 |
89,571,657 |
RGD:6480464 |
CTD |
| G |
Nkiras2 |
NFKB inhibitor interacting Ras-like 2 |
|
multiple interactions |
ISO |
10 |
89,567,630 |
89,571,657 |
RGD:6480464 |
CTD |
| G |
Nkx1-2 |
NK1 homeobox 2 |
|
decreases expression |
EXP |
1 |
192,068,166 |
192,070,602 |
RGD:6480464 |
CTD |
| G |
Nlk |
nemo like kinase |
|
increases expression |
ISO |
10 |
64,681,240 |
64,804,942 |
RGD:6480464 |
CTD |
| G |
Nlk |
nemo like kinase |
|
multiple interactions |
ISO |
10 |
64,681,240 |
64,804,942 |
RGD:6480464 |
CTD |
| G |
Nlrp6 |
NLR family, pyrin domain containing 6 |
|
multiple interactions |
ISO |
1 |
201,085,759 |
201,091,919 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
affects expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
multiple interactions |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
increases expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
multiple interactions |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
increases expression |
EXP |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
|
decreases expression |
EXP |
10 |
15,360,310 |
15,364,165 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
affects expression |
ISO |
8 |
114,205,773 |
114,212,486 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
multiple interactions |
ISO |
8 |
114,205,773 |
114,212,486 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
increases expression |
ISO |
8 |
114,205,773 |
114,212,486 |
RGD:6480464 |
CTD |
| G |
Nmi |
N-myc (and STAT) interactor |
|
increases expression |
EXP |
3 |
32,962,021 |
32,996,031 |
RGD:6480464 |
CTD |
| G |
Nmral1 |
NmrA-like family domain containing 1 |
|
decreases expression |
EXP |
10 |
10,971,190 |
10,979,379 |
RGD:6480464 |
CTD |
| G |
Nmur2 |
neuromedin U receptor 2 |
|
increases expression |
EXP |
10 |
41,471,179 |
41,485,043 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
increases expression |
ISO |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
affects expression |
ISO |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
multiple interactions |
ISO |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nnat |
neuronatin |
|
decreases expression |
EXP |
3 |
148,269,404 |
148,271,781 |
RGD:6480464 |
CTD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
multiple interactions |
ISO |
8 |
51,871,506 |
51,883,785 |
RGD:6480464 |
CTD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
affects expression |
ISO |
8 |
51,871,506 |
51,883,785 |
RGD:6480464 |
CTD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
increases expression |
ISO |
8 |
51,871,506 |
51,883,785 |
RGD:6480464 |
CTD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
decreases expression |
EXP |
8 |
51,871,506 |
51,883,785 |
RGD:6480464 |
CTD |
| G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
affects expression |
EXP |
2 |
51,496,456 |
51,589,901 |
RGD:6480464 |
CTD |
| G |
Nol7 |
nucleolar protein 7 |
|
multiple interactions |
ISO |
17 |
27,127,979 |
27,132,484 |
RGD:6480464 |
CTD |
| G |
Nol7 |
nucleolar protein 7 |
|
increases expression |
ISO |
17 |
27,127,979 |
27,132,484 |
RGD:6480464 |
CTD |
| G |
Nol8 |
nucleolar protein 8 |
|
increases expression |
ISO |
17 |
20,945,380 |
20,968,740 |
RGD:6480464 |
CTD |
| G |
Nol8 |
nucleolar protein 8 |
|
multiple interactions |
ISO |
17 |
20,945,380 |
20,968,740 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
decreases expression |
EXP |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nomo1 |
nodal modulator 1 |
|
affects expression |
ISO |
1 |
96,528,675 |
96,579,476 |
RGD:6480464 |
CTD |
| G |
Nsg2 |
neuron specific gene family member 2 |
|
affects expression |
ISO |
10 |
15,849,138 |
15,909,029 |
RGD:6480464 |
CTD |
| G |
Nsun6 |
NOP2/Sun domain family, member 6 |
|
affects expression |
ISO |
17 |
89,082,141 |
89,120,005 |
RGD:6480464 |
CTD |
| G |
Nsun6 |
NOP2/Sun domain family, member 6 |
|
increases expression |
ISO |
17 |
89,082,141 |
89,120,005 |
RGD:6480464 |
CTD |
| G |
Nsun6 |
NOP2/Sun domain family, member 6 |
|
multiple interactions |
ISO |
17 |
89,082,141 |
89,120,005 |
RGD:6480464 |
CTD |
| G |
Nt5c1b |
5'-nucleotidase, cytosolic IB |
|
increases expression |
ISO |
6 |
33,849,953 |
33,867,624 |
RGD:6480464 |
CTD |
| G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
multiple interactions |
ISO |
1 |
252,204,106 |
252,329,479 |
RGD:6480464 |
CTD |
| G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
increases expression |
ISO |
1 |
252,204,106 |
252,329,479 |
RGD:6480464 |
CTD |
| G |
Nt5c3a |
5'-nucleotidase, cytosolic IIIA |
|
multiple interactions |
ISO |
4 |
85,870,878 |
85,913,812 |
RGD:6480464 |
CTD |
| G |
Nt5c3a |
5'-nucleotidase, cytosolic IIIA |
|
increases expression |
ISO |
4 |
85,870,878 |
85,913,812 |
RGD:6480464 |
CTD |
| G |
Nt5m |
5',3'-nucleotidase, mitochondrial |
|
affects expression |
ISO |
10 |
46,174,806 |
46,200,790 |
RGD:6480464 |
CTD |
| G |
Nt5m |
5',3'-nucleotidase, mitochondrial |
|
multiple interactions |
ISO |
10 |
46,174,806 |
46,200,790 |
RGD:6480464 |
CTD |
| G |
Ntan1 |
N-terminal asparagine amidase |
|
affects expression |
ISO |
10 |
1,531,025 |
1,545,977 |
RGD:6480464 |
CTD |
| G |
Ntan1 |
N-terminal asparagine amidase |
|
increases expression |
ISO |
10 |
1,531,025 |
1,545,977 |
RGD:6480464 |
CTD |
| G |
Ntan1 |
N-terminal asparagine amidase |
|
multiple interactions |
ISO |
10 |
1,531,025 |
1,545,977 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
affects expression |
ISO |
10 |
13,883,284 |
13,889,790 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
multiple interactions |
ISO |
10 |
13,883,284 |
13,889,790 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
increases expression |
EXP |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Nucb1 |
nucleobindin 1 |
|
affects expression |
ISO |
1 |
95,961,163 |
95,981,910 |
RGD:6480464 |
CTD |
| G |
Nucb1 |
nucleobindin 1 |
|
increases expression |
ISO |
1 |
95,961,163 |
95,981,910 |
RGD:6480464 |
CTD |
| G |
Nucb1 |
nucleobindin 1 |
|
multiple interactions |
ISO |
1 |
95,961,163 |
95,981,910 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
increases expression |
ISO |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
multiple interactions |
ISO |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
affects expression |
ISO |
6 |
142,904,062 |
142,905,783 |
RGD:6480464 |
CTD |
| G |
Nudc |
nuclear distribution C homolog (A. nidulans) |
|
affects expression |
ISO |
5 |
151,535,900 |
151,550,041 |
RGD:6480464 |
CTD |
| G |
Nudc |
nuclear distribution C homolog (A. nidulans) |
|
increases expression |
ISO |
5 |
151,535,900 |
151,550,041 |
RGD:6480464 |
CTD |
| G |
Nudc |
nuclear distribution C homolog (A. nidulans) |
|
multiple interactions |
ISO |
5 |
151,535,900 |
151,550,041 |
RGD:6480464 |
CTD |
| G |
Nudt1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
|
increases expression |
ISO |
12 |
14,775,536 |
14,778,845 |
RGD:6480464 |
CTD |
| G |
Nudt1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
|
multiple interactions |
ISO |
12 |
14,775,536 |
14,778,845 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression |
ISO |
7 |
32,753,728 |
32,769,953 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
multiple interactions |
ISO |
7 |
32,753,728 |
32,769,953 |
RGD:6480464 |
CTD |
| G |
Nudt4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
|
increases expression |
EXP |
7 |
32,753,728 |
32,769,953 |
RGD:6480464 |
CTD |
| G |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
affects expression |
ISO |
2 |
123,947,307 |
123,962,639 |
RGD:6480464 |
CTD |
| G |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
increases expression |
ISO |
2 |
123,947,307 |
123,962,639 |
RGD:6480464 |
CTD |
| G |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
|
multiple interactions |
ISO |
2 |
123,947,307 |
123,962,639 |
RGD:6480464 |
CTD |
| G |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
|
increases expression |
ISO |
19 |
44,181,782 |
44,196,976 |
RGD:6480464 |
CTD |
| G |
Nudt8 |
nudix (nucleoside diphosphate linked moiety X)-type motif 8 |
|
multiple interactions |
ISO |
1 |
206,583,181 |
206,584,885 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Nufip1 |
nuclear fragile X mental retardation protein interacting protein 1 |
|
multiple interactions |
ISO |
15 |
57,028,109 |
57,058,834 |
RGD:6480464 |
CTD |
| G |
Nup133 |
nucleoporin 133 |
|
multiple interactions |
ISO |
19 |
54,089,391 |
54,139,882 |
RGD:6480464 |
CTD |
| G |
Nup153 |
nucleoporin 153 |
|
multiple interactions |
ISO |
17 |
24,031,666 |
24,084,210 |
RGD:6480464 |
CTD |
| G |
Nup155 |
nucleoporin 155 |
|
increases expression |
ISO |
2 |
57,711,414 |
57,762,974 |
RGD:6480464 |
CTD |
| G |
Nup155 |
nucleoporin 155 |
|
multiple interactions |
ISO |
2 |
57,711,414 |
57,762,974 |
RGD:6480464 |
CTD |
| G |
Nup160 |
nucleoporin 160 |
|
increases expression |
ISO |
3 |
75,041,873 |
75,102,540 |
RGD:6480464 |
CTD |
| G |
Nup35 |
nucleoporin 35 |
|
increases expression |
ISO |
3 |
63,493,936 |
63,519,689 |
RGD:6480464 |
CTD |
| G |
Nup35 |
nucleoporin 35 |
|
multiple interactions |
ISO |
3 |
63,493,936 |
63,519,689 |
RGD:6480464 |
CTD |
| G |
Os9 |
osteosarcoma amplified 9 |
|
affects expression |
ISO |
7 |
67,046,802 |
67,073,355 |
RGD:6480464 |
CTD |
| G |
Ostf1 |
osteoclast stimulating factor 1 |
|
multiple interactions |
ISO |
1 |
222,182,802 |
222,229,865 |
RGD:6480464 |
CTD |
| G |
Ostf1 |
osteoclast stimulating factor 1 |
|
increases expression |
EXP |
1 |
222,182,802 |
222,229,865 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
decreases expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Otof |
otoferlin |
|
multiple interactions |
ISO |
6 |
25,912,607 |
26,008,137 |
RGD:6480464 |
CTD |
| G |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
|
affects expression |
ISO |
6 |
127,679,755 |
127,698,318 |
RGD:6480464 |
CTD |
| G |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
|
increases expression |
ISO |
6 |
127,679,755 |
127,698,318 |
RGD:6480464 |
CTD |
| G |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
|
multiple interactions |
ISO |
6 |
127,679,755 |
127,698,318 |
RGD:6480464 |
CTD |
| G |
Otud5 |
OTU domain containing 5 |
|
affects expression |
ISO |
X |
26,660,722 |
26,693,208 |
RGD:6480464 |
CTD |
| G |
Ovol1 |
ovo-like 1(Drosophila) |
|
increases expression |
ISO |
1 |
208,192,952 |
208,204,453 |
RGD:6480464 |
CTD |
| G |
Ovol1 |
ovo-like 1(Drosophila) |
|
multiple interactions |
ISO |
1 |
208,192,952 |
208,204,453 |
RGD:6480464 |
CTD |
| G |
Ovol2 |
ovo-like 2 (Drosophila) |
|
increases expression |
ISO |
3 |
132,842,267 |
132,871,206 |
RGD:6480464 |
CTD |
| G |
Ovol2 |
ovo-like 2 (Drosophila) |
|
multiple interactions |
ISO |
3 |
132,842,267 |
132,871,206 |
RGD:6480464 |
CTD |
| G |
Oxa1l |
oxidase (cytochrome c) assembly 1-like |
|
affects expression |
ISO |
15 |
32,423,349 |
32,430,976 |
RGD:6480464 |
CTD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
multiple interactions |
ISO |
2 |
53,189,358 |
53,217,848 |
RGD:6480464 |
CTD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
affects expression |
ISO |
2 |
53,189,358 |
53,217,848 |
RGD:6480464 |
CTD |
| G |
Oxct2b |
3-oxoacid CoA transferase 2B |
|
affects expression |
ISO |
5 |
142,432,259 |
142,434,013 |
RGD:6480464 |
CTD |
| G |
Oxct2b |
3-oxoacid CoA transferase 2B |
|
multiple interactions |
ISO |
5 |
142,432,259 |
142,434,013 |
RGD:6480464 |
CTD |
| G |
Oxct2b |
3-oxoacid CoA transferase 2B |
|
increases expression |
ISO |
5 |
142,432,259 |
142,434,013 |
RGD:6480464 |
CTD |
| G |
Oxr1 |
oxidation resistance 1 |
|
affects expression |
ISO |
7 |
77,427,877 |
77,501,800 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases expression |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
increases activity |
EXP |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
Oxtr |
oxytocin receptor |
|
increases expression |
EXP |
4 |
148,314,089 |
148,326,797 |
RGD:6480464 |
CTD |
| G |
P2rx2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
ISO |
12 |
46,485,125 |
46,488,319 |
RGD:6480464 |
CTD |
| G |
P2rx3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
|
affects expression |
EXP |
3 |
68,228,045 |
68,270,751 |
RGD:6480464 |
CTD |
| G |
P2ry6 |
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
|
increases expression |
EXP |
1 |
158,381,127 |
158,406,783 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
affects expression |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
increases expression |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
P4ha2 |
prolyl 4-hydroxylase, alpha polypeptide II |
|
multiple interactions |
ISO |
10 |
39,522,157 |
39,551,063 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
affects expression |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
multiple interactions |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
increases expression |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
decreases expression |
EXP |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
increases expression |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Pa2g4 |
proliferation-associated 2G4 |
|
multiple interactions |
ISO |
7 |
1,846,628 |
1,854,096 |
RGD:6480464 |
CTD |
| G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
increases expression |
ISO |
7 |
72,116,140 |
72,128,433 |
RGD:6480464 |
CTD |
| G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
multiple interactions |
ISO |
7 |
72,116,140 |
72,128,433 |
RGD:6480464 |
CTD |
| G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
increases expression |
EXP |
7 |
72,116,140 |
72,128,433 |
RGD:6480464 |
CTD |
| G |
Pacrg |
Park2 co-regulated |
|
multiple interactions |
ISO |
1 |
44,374,745 |
44,836,465 |
RGD:6480464 |
CTD |
| G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
decreases expression |
EXP |
1 |
207,750,953 |
207,903,865 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
increases expression |
ISO |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
affects expression |
ISO |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
|
multiple interactions |
ISO |
7 |
121,484,248 |
121,546,498 |
RGD:6480464 |
CTD |
| G |
Padi1 |
peptidyl arginine deiminase, type I |
|
increases expression |
EXP |
5 |
159,671,725 |
159,704,188 |
RGD:6480464 |
CTD |
| G |
Padi2 |
peptidyl arginine deiminase, type II |
|
increases expression |
ISO |
5 |
159,762,824 |
159,805,399 |
RGD:6480464 |
CTD |
| G |
Padi2 |
peptidyl arginine deiminase, type II |
|
affects expression |
ISO |
5 |
159,762,824 |
159,805,399 |
RGD:6480464 |
CTD |
| G |
Padi4 |
peptidyl arginine deiminase, type IV |
|
increases expression |
EXP |
5 |
159,580,718 |
159,614,628 |
RGD:6480464 |
CTD |
| G |
Pafah1b1 |
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 |
|
increases expression |
ISO |
10 |
61,955,348 |
62,037,871 |
RGD:6480464 |
CTD |
| G |
Pank2 |
pantothenate kinase 2 |
|
multiple interactions |
ISO |
3 |
118,970,527 |
119,004,728 |
RGD:6480464 |
CTD |
| G |
Papss1 |
3'-phosphoadenosine 5'-phosphosulfate synthase 1 |
|
increases expression |
EXP |
2 |
229,005,799 |
229,040,958 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
affects expression |
EXP |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
affects expression |
ISO |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
decreases expression |
EXP |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
affects expression |
ISO |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pcca |
propionyl CoA carboxylase, alpha polypeptide |
|
increases expression |
ISO |
15 |
107,659,723 |
108,028,929 |
RGD:6480464 |
CTD |
| G |
Pcca |
propionyl CoA carboxylase, alpha polypeptide |
|
increases expression |
ISO |
15 |
107,659,723 |
108,028,929 |
RGD:6480464 |
CTD |
| G |
Pcca |
propionyl CoA carboxylase, alpha polypeptide |
|
multiple interactions |
ISO |
15 |
107,659,723 |
108,028,929 |
RGD:6480464 |
CTD |
| G |
Pcp4 |
Purkinje cell protein 4 |
|
multiple interactions |
ISO |
11 |
36,828,273 |
36,889,381 |
RGD:6480464 |
CTD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
increases expression |
EXP |
2 |
1,923,309 |
1,970,238 |
RGD:6480464 |
CTD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
affects expression |
ISO |
3 |
131,925,648 |
132,256,178 |
RGD:6480464 |
CTD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
increases expression |
ISO |
3 |
131,925,648 |
132,256,178 |
RGD:6480464 |
CTD |
| G |
Pcsk2 |
proprotein convertase subtilisin/kexin type 2 |
|
increases expression |
EXP |
3 |
131,925,648 |
132,256,178 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
affects expression |
ISO |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
increases expression |
ISO |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
multiple interactions |
ISO |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
increases expression |
EXP |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
|
multiple interactions |
ISO |
8 |
48,879,382 |
48,901,968 |
RGD:6480464 |
CTD |
| G |
Pctp |
phosphatidylcholine transfer protein |
|
increases expression |
EXP |
10 |
78,400,328 |
78,420,774 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
multiple interactions |
ISO |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
increases expression |
ISO |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pdap1 |
PDGFA associated protein 1 |
|
increases expression |
ISO |
12 |
9,784,744 |
9,794,971 |
RGD:6480464 |
CTD |
| G |
Pdap1 |
PDGFA associated protein 1 |
|
multiple interactions |
ISO |
12 |
9,784,744 |
9,794,971 |
RGD:6480464 |
CTD |
| G |
Pdcd1 |
programmed cell death 1 |
|
affects expression |
ISO |
9 |
93,172,543 |
93,185,687 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
affects expression |
ISO |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
multiple interactions |
ISO |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pdcd2 |
programmed cell death 2 |
|
increases expression |
ISO |
1 |
54,412,081 |
54,417,571 |
RGD:6480464 |
CTD |
| G |
Pdcd5 |
programmed cell death 5 |
|
increases expression |
EXP |
1 |
88,194,319 |
88,199,647 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
affects expression |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
multiple interactions |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pdcd6ip |
programmed cell death 6 interacting protein |
|
increases expression |
EXP |
8 |
118,314,910 |
118,350,134 |
RGD:6480464 |
CTD |
| G |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
|
multiple interactions |
ISO |
3 |
62,650,092 |
62,928,487 |
RGD:6480464 |
CTD |
| G |
Pde4dip |
phosphodiesterase 4D interacting protein |
|
multiple interactions |
ISO |
2 |
192,534,747 |
192,671,053 |
RGD:6480464 |
CTD |
| G |
Pde6d |
phosphodiesterase 6D, cGMP-specific, rod, delta |
|
multiple interactions |
ISO |
9 |
85,307,907 |
85,352,836 |
RGD:6480464 |
CTD |
| G |
Pde6d |
phosphodiesterase 6D, cGMP-specific, rod, delta |
|
increases expression |
ISO |
9 |
85,307,907 |
85,352,836 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
decreases expression |
ISO |
1 |
137,415,852 |
137,544,337 |
RGD:6480464 |
CTD |
| G |
Pde9a |
phosphodiesterase 9A |
|
affects expression |
ISO |
20 |
9,806,117 |
9,901,584 |
RGD:6480464 |
CTD |
| G |
Pde9a |
phosphodiesterase 9A |
|
increases expression |
ISO |
20 |
9,806,117 |
9,901,584 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
increases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
affects expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
decreases expression |
EXP |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdha1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
|
multiple interactions |
ISO |
X |
55,899,491 |
55,913,319 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
multiple interactions |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
increases expression |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdhx |
pyruvate dehydrogenase complex, component X |
|
multiple interactions |
ISO |
3 |
88,240,250 |
88,270,914 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
decreases expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
increases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
multiple interactions |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
affects expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
affects expression |
ISO |
10 |
83,710,448 |
83,724,973 |
RGD:6480464 |
CTD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
affects expression |
ISO |
20 |
10,541,656 |
10,563,199 |
RGD:6480464 |
CTD |
| G |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
|
multiple interactions |
ISO |
7 |
116,880,751 |
116,886,199 |
RGD:6480464 |
CTD |
| G |
Pgrmc1 |
progesterone receptor membrane component 1 |
|
affects expression |
ISO |
X |
8,265,543 |
8,273,667 |
RGD:6480464 |
CTD |
| G |
Pgrmc2 |
progesterone receptor membrane component 2 |
|
affects expression |
ISO |
2 |
128,025,076 |
128,040,975 |
RGD:6480464 |
CTD |
| G |
Pgs1 |
phosphatidylglycerophosphate synthase 1 |
|
affects expression |
ISO |
10 |
107,978,636 |
108,009,997 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
increases expression |
ISO |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
multiple interactions |
ISO |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
affects expression |
ISO |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
increases expression |
EXP |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
decreases expression |
EXP |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Phc2 |
polyhomeotic homolog 2 (Drosophila) |
|
affects expression |
ISO |
5 |
147,930,703 |
147,978,856 |
RGD:6480464 |
CTD |
| G |
Phc2 |
polyhomeotic homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
5 |
147,930,703 |
147,978,856 |
RGD:6480464 |
CTD |
| G |
Phc2 |
polyhomeotic homolog 2 (Drosophila) |
|
increases expression |
ISO |
5 |
147,930,703 |
147,978,856 |
RGD:6480464 |
CTD |
| G |
Phf17 |
PHD finger protein 17 |
|
affects expression |
ISO |
2 |
128,499,983 |
128,553,050 |
RGD:6480464 |
CTD |
| G |
Phf23 |
PHD finger protein 23 |
|
affects expression |
ISO |
10 |
56,841,624 |
56,846,146 |
RGD:6480464 |
CTD |
| G |
Phf5a |
PHD finger protein 5A |
|
affects expression |
ISO |
7 |
120,216,581 |
120,223,146 |
RGD:6480464 |
CTD |
| G |
Phf5a |
PHD finger protein 5A |
|
multiple interactions |
ISO |
7 |
120,216,581 |
120,223,146 |
RGD:6480464 |
CTD |
| G |
Phf5a |
PHD finger protein 5A |
|
increases expression |
ISO |
7 |
120,216,581 |
120,223,146 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
affects expression |
ISO |
16 |
6,671,312 |
6,684,015 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
multiple interactions |
ISO |
16 |
6,671,312 |
6,684,015 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
increases expression |
ISO |
16 |
6,671,312 |
6,684,015 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
ISO |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
multiple interactions |
ISO |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
decreases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phkg2 |
phosphorylase kinase, gamma 2 (testis) |
|
affects expression |
ISO |
1 |
186,858,077 |
186,870,601 |
RGD:6480464 |
CTD |
| G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
|
multiple interactions |
ISO |
1 |
203,878,093 |
203,879,038 |
RGD:6480464 |
CTD |
| G |
Phldb1 |
pleckstrin homology-like domain, family B, member 1 |
|
increases expression |
ISO |
8 |
47,645,164 |
47,686,143 |
RGD:6480464 |
CTD |
| G |
Phldb1 |
pleckstrin homology-like domain, family B, member 1 |
|
multiple interactions |
ISO |
8 |
47,645,164 |
47,686,143 |
RGD:6480464 |
CTD |
| G |
Phospho2 |
phosphatase, orphan 2 |
|
affects expression |
ISO |
3 |
51,937,823 |
51,944,984 |
RGD:6480464 |
CTD |
| G |
Phox2a |
paired-like homeobox 2a |
|
increases expression |
ISO |
1 |
159,273,524 |
159,312,136 |
RGD:6480464 |
CTD |
| G |
Phox2a |
paired-like homeobox 2a |
|
multiple interactions |
ISO |
1 |
159,273,524 |
159,312,136 |
RGD:6480464 |
CTD |
| G |
Phpt1 |
phosphohistidine phosphatase 1 |
|
affects expression |
ISO |
3 |
3,744,947 |
3,746,346 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
decreases expression |
EXP |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
multiple interactions |
ISO |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Phyhip |
phytanoyl-CoA 2-hydroxylase interacting protein |
|
multiple interactions |
ISO |
15 |
50,860,503 |
50,871,752 |
RGD:6480464 |
CTD |
| G |
Pias2 |
protein inhibitor of activated STAT, 2 |
|
increases expression |
ISO |
18 |
74,078,683 |
74,123,668 |
RGD:6480464 |
CTD |
| G |
Pias2 |
protein inhibitor of activated STAT, 2 |
|
multiple interactions |
ISO |
18 |
74,078,683 |
74,123,668 |
RGD:6480464 |
CTD |
| G |
Pias3 |
protein inhibitor of activated STAT, 3 |
|
affects expression |
EXP |
2 |
191,499,057 |
191,507,221 |
RGD:6480464 |
CTD |
| G |
Pias3 |
protein inhibitor of activated STAT, 3 |
|
decreases expression |
EXP |
2 |
191,499,057 |
191,507,221 |
RGD:6480464 |
CTD |
| G |
Pick1 |
protein interacting with PRKCA 1 |
|
affects expression |
ISO |
7 |
117,213,299 |
117,232,651 |
RGD:6480464 |
CTD |
| G |
Pick1 |
protein interacting with PRKCA 1 |
|
increases expression |
ISO |
7 |
117,213,299 |
117,232,651 |
RGD:6480464 |
CTD |
| G |
Pick1 |
protein interacting with PRKCA 1 |
|
multiple interactions |
ISO |
7 |
117,213,299 |
117,232,651 |
RGD:6480464 |
CTD |
| G |
Piezo2 |
piezo-type mechanosensitive ion channel component 2 |
|
decreases expression |
EXP |
18 |
59,147,791 |
59,531,873 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
affects expression |
ISO |
X |
50,797,413 |
50,812,217 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
affects expression |
ISO |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
|
multiple interactions |
ISO |
2 |
250,976,109 |
251,037,852 |
RGD:6480464 |
CTD |
| G |
Pkn3 |
protein kinase N3 |
|
affects expression |
ISO |
3 |
9,068,176 |
9,096,114 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
multiple interactions |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcg2 |
phospholipase C, gamma 2 |
|
increases expression |
ISO |
19 |
47,875,572 |
47,947,573 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
multiple interactions |
ISO |
10 |
57,388,474 |
57,439,063 |
RGD:6480464 |
CTD |
| G |
Plek2 |
pleckstrin 2 |
|
affects expression |
ISO |
6 |
101,523,558 |
101,541,773 |
RGD:6480464 |
CTD |
| G |
Plek2 |
pleckstrin 2 |
|
multiple interactions |
ISO |
6 |
101,523,558 |
101,541,773 |
RGD:6480464 |
CTD |
| G |
Plek2 |
pleckstrin 2 |
|
increases expression |
ISO |
6 |
101,523,558 |
101,541,773 |
RGD:6480464 |
CTD |
| G |
Plekha2 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Plekha2 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Plekha3 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 3 |
|
increases expression |
ISO |
3 |
59,375,462 |
59,396,674 |
RGD:6480464 |
CTD |
| G |
Plekha3 |
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 3 |
|
multiple interactions |
ISO |
3 |
59,375,462 |
59,396,674 |
RGD:6480464 |
CTD |
| G |
Plekhb1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
|
increases expression |
ISO |
1 |
158,081,932 |
158,096,197 |
RGD:6480464 |
CTD |
| G |
Plekhb1 |
pleckstrin homology domain containing, family B (evectins) member 1 |
|
multiple interactions |
ISO |
1 |
158,081,932 |
158,096,197 |
RGD:6480464 |
CTD |
| G |
Plekhb2 |
pleckstrin homology domain containing, family B (evectins) member 2 |
|
affects expression |
ISO |
9 |
33,585,361 |
33,618,323 |
RGD:6480464 |
CTD |
| G |
Plekhb2 |
pleckstrin homology domain containing, family B (evectins) member 2 |
|
multiple interactions |
ISO |
9 |
33,585,361 |
33,618,323 |
RGD:6480464 |
CTD |
| G |
Plekhg2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
|
multiple interactions |
ISO |
1 |
83,469,392 |
83,482,599 |
RGD:6480464 |
CTD |
| G |
Plekhh2 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
|
increases expression |
ISO |
6 |
7,887,555 |
7,986,077 |
RGD:6480464 |
CTD |
| G |
Plekhh2 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
|
multiple interactions |
ISO |
6 |
7,887,555 |
7,986,077 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
multiple interactions |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
multiple interactions |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
multiple interactions |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
multiple interactions |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
increases expression |
ISO |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plk1s1 |
polo-like kinase 1 substrate 1 |
|
decreases expression |
EXP |
3 |
135,488,158 |
135,598,982 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
affects expression |
ISO |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Plk2 |
polo-like kinase 2 |
|
increases expression |
EXP |
2 |
41,800,745 |
41,806,503 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
multiple interactions |
ISO |
5 |
137,443,540 |
137,448,715 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
increases expression |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
multiple interactions |
ISO |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
affects expression |
EXP |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Plod2 |
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression |
EXP |
8 |
97,525,279 |
97,623,152 |
RGD:6480464 |
CTD |
| G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
|
multiple interactions |
ISO |
12 |
20,856,527 |
20,867,088 |
RGD:6480464 |
CTD |
| G |
Plrg1 |
pleiotropic regulator 1 |
|
affects expression |
ISO |
2 |
174,780,415 |
174,796,746 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
decreases expression |
EXP |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
affects expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Pltp |
phospholipid transfer protein |
|
decreases expression |
ISO |
3 |
155,871,842 |
155,889,959 |
RGD:6480464 |
CTD |
| G |
Plxdc2 |
plexin domain containing 2 |
|
multiple interactions |
ISO |
17 |
90,572,391 |
90,982,074 |
RGD:6480464 |
CTD |
| G |
Plxna4a |
plexin A4, A |
|
affects expression |
ISO |
4 |
59,254,319 |
59,692,187 |
RGD:6480464 |
CTD |
| G |
Plxna4a |
plexin A4, A |
|
decreases expression |
ISO |
4 |
59,254,319 |
59,692,187 |
RGD:6480464 |
CTD |
| G |
Plxna4a |
plexin A4, A |
|
affects expression |
ISO |
4 |
59,254,319 |
59,692,187 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
affects expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmfbp1 |
polyamine modulated factor 1 binding protein 1 |
|
affects expression |
ISO |
19 |
39,346,490 |
39,411,270 |
RGD:6480464 |
CTD |
| G |
Pmm1 |
phosphomannomutase 1 |
|
increases expression |
ISO |
7 |
120,323,808 |
120,334,065 |
RGD:6480464 |
CTD |
| G |
Pmm1 |
phosphomannomutase 1 |
|
multiple interactions |
ISO |
7 |
120,323,808 |
120,334,065 |
RGD:6480464 |
CTD |
| G |
Pmpca |
peptidase (mitochondrial processing) alpha |
|
multiple interactions |
ISO |
3 |
4,560,961 |
4,568,758 |
RGD:6480464 |
CTD |
| G |
Pop5 |
processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae) |
|
multiple interactions |
ISO |
12 |
42,644,912 |
42,649,407 |
RGD:6480464 |
CTD |
| G |
Pop7 |
processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) |
|
multiple interactions |
ISO |
12 |
19,570,020 |
19,571,061 |
RGD:6480464 |
CTD |
| G |
Popdc2 |
popeye domain containing 2 |
|
affects expression |
ISO |
11 |
64,154,286 |
64,170,282 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
multiple interactions |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Porcn |
porcupine homolog (Drosophila) |
|
affects expression |
ISO |
X |
26,317,388 |
26,330,177 |
RGD:6480464 |
CTD |
| G |
Porcn |
porcupine homolog (Drosophila) |
|
increases expression |
ISO |
X |
26,317,388 |
26,330,177 |
RGD:6480464 |
CTD |
| G |
Porf1 |
preoptic regulatory factor 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
decreases expression |
EXP |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Postn |
periostin, osteoblast specific factor |
|
affects expression |
ISO |
2 |
143,537,099 |
143,568,341 |
RGD:6480464 |
CTD |
| G |
Pot1 |
protection of telomeres 1 |
|
affects expression |
ISO |
4 |
52,233,404 |
52,289,574 |
RGD:6480464 |
CTD |
| G |
Pou2af1 |
POU class 2 associating factor 1 |
|
decreases expression |
ISO |
8 |
54,534,417 |
54,561,348 |
RGD:6480464 |
CTD |
| G |
Pou2f1 |
POU class 2 homeobox 1 |
|
decreases expression |
EXP |
13 |
81,607,326 |
81,739,958 |
RGD:6480464 |
CTD |
| G |
Ppan |
peter pan homolog (Drosophila) |
|
increases expression |
ISO |
8 |
19,909,814 |
19,915,460 |
RGD:6480464 |
CTD |
| G |
Ppan |
peter pan homolog (Drosophila) |
|
affects expression |
ISO |
8 |
19,909,814 |
19,915,460 |
RGD:6480464 |
CTD |
| G |
Ppan |
peter pan homolog (Drosophila) |
|
multiple interactions |
ISO |
8 |
19,909,814 |
19,915,460 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
increases expression |
ISO |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
multiple interactions |
ISO |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
affects expression |
EXP |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
affects expression |
ISO |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
decreases expression |
EXP |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppap2c |
phosphatidic acid phosphatase type 2c |
|
increases expression |
EXP |
7 |
11,694,272 |
11,702,348 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppcs |
phosphopantothenoylcysteine synthetase |
|
affects expression |
ISO |
5 |
140,008,434 |
140,012,295 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
EXP |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
EXP |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prg4 |
proteoglycan 4 |
|
multiple interactions |
ISO |
13 |
64,753,316 |
64,769,533 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
affects expression |
ISO |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
decreases expression |
ISO |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
multiple interactions |
ISO |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
increases expression |
ISO |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A (S. pombe) |
|
increases expression |
ISO |
1 |
206,778,534 |
206,785,230 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A (S. pombe) |
|
multiple interactions |
ISO |
1 |
206,778,534 |
206,785,230 |
RGD:6480464 |
CTD |
| G |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
|
affects expression |
ISO |
3 |
12,146,421 |
12,379,365 |
RGD:6480464 |
CTD |
| G |
Ralgps1 |
Ral GEF with PH domain and SH3 binding motif 1 |
|
increases expression |
ISO |
3 |
12,146,421 |
12,379,365 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
multiple interactions |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
affects expression |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbbp6 |
retinoblastoma binding protein 6 |
|
affects expression |
ISO |
1 |
181,818,248 |
181,849,942 |
RGD:6480464 |
CTD |
| G |
Reg3a |
regenerating islet-derived 3 alpha |
|
increases expression |
EXP |
4 |
112,366,001 |
112,368,767 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
decreases expression |
EXP |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
decreases expression |
ISO |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
multiple interactions |
ISO |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rere |
arginine-glutamic acid dipeptide (RE) repeats |
|
affects expression |
ISO |
5 |
167,440,122 |
167,777,271 |
RGD:6480464 |
CTD |
| G |
Rnft1 |
ring finger protein, transmembrane 1 |
|
affects expression |
ISO |
10 |
76,640,223 |
76,651,484 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
decreases expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor A |
|
affects expression |
ISO |
8 |
73,052,282 |
73,817,764 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
decreases expression |
EXP |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
decreases expression |
ISO |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
increases expression |
EXP |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rpl7a |
ribosomal protein L7a |
|
increases expression |
EXP |
18 |
5,807,901 |
5,810,543 |
RGD:6480464 |
CTD |
| G |
Rpl7a |
ribosomal protein L7a |
|
multiple interactions |
ISO |
18 |
5,807,901 |
5,810,543 |
RGD:6480464 |
CTD |
| G |
Rps2 |
ribosomal protein S2 |
|
multiple interactions |
ISO |
10 |
13,975,350 |
13,977,199 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
increases expression |
ISO |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Rps27l2 |
ribosomal protein S27-like 2 |
|
affects expression |
ISO |
12 |
29,143,461 |
29,143,842 |
RGD:6480464 |
CTD |
| G |
Rundc3a |
RUN domain containing 3A |
|
multiple interactions |
ISO |
10 |
91,501,018 |
91,510,151 |
RGD:6480464 |
CTD |
| G |
Sec61g |
SEC61, gamma subunit |
|
multiple interactions |
ISO |
14 |
97,323,315 |
97,329,689 |
RGD:6480464 |
CTD |
| G |
Sec61g |
SEC61, gamma subunit |
|
increases expression |
ISO |
14 |
97,323,315 |
97,329,689 |
RGD:6480464 |
CTD |
| G |
Serf2 |
small EDRK-rich factor 2 |
|
multiple interactions |
ISO |
3 |
108,255,260 |
108,258,848 |
RGD:6480464 |
CTD |
| G |
Serf2 |
small EDRK-rich factor 2 |
|
decreases expression |
EXP |
3 |
108,255,260 |
108,258,848 |
RGD:6480464 |
CTD |
| G |
Serf2 |
small EDRK-rich factor 2 |
|
increases expression |
ISO |
3 |
108,255,260 |
108,258,848 |
RGD:6480464 |
CTD |
| G |
Setdb1 |
SET domain, bifurcated 1 |
|
increases expression |
ISO |
2 |
190,232,228 |
190,264,309 |
RGD:6480464 |
CTD |
| G |
Setdb1 |
SET domain, bifurcated 1 |
|
multiple interactions |
ISO |
2 |
190,232,228 |
190,264,309 |
RGD:6480464 |
CTD |
| G |
Slc16a11 |
solute carrier family 16, member 11 (monocarboxylic acid transporter 11) |
|
decreases expression |
EXP |
10 |
57,051,553 |
57,055,276 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
increases expression |
EXP |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc9b2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
|
affects expression |
ISO |
2 |
232,789,603 |
232,833,880 |
RGD:6480464 |
CTD |
| G |
Slc9b2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
|
affects expression |
ISO |
2 |
232,789,603 |
232,833,880 |
RGD:6480464 |
CTD |
| G |
Smyd5 |
SMYD family member 5 |
|
increases expression |
ISO |
4 |
119,686,587 |
119,701,588 |
RGD:6480464 |
CTD |
| G |
Smyd5 |
SMYD family member 5 |
|
multiple interactions |
ISO |
4 |
119,686,587 |
119,701,588 |
RGD:6480464 |
CTD |
| G |
Snrpa1 |
small nuclear ribonucleoprotein polypeptide A' |
|
affects expression |
ISO |
1 |
120,490,921 |
120,503,974 |
RGD:6480464 |
CTD |
| G |
Snrpa1 |
small nuclear ribonucleoprotein polypeptide A' |
|
increases expression |
ISO |
1 |
120,490,921 |
120,503,974 |
RGD:6480464 |
CTD |
| G |
Snrpa1 |
small nuclear ribonucleoprotein polypeptide A' |
|
multiple interactions |
ISO |
1 |
120,490,921 |
120,503,974 |
RGD:6480464 |
CTD |
| G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
|
increases expression |
ISO |
13 |
46,522,340 |
46,528,589 |
RGD:6480464 |
CTD |
| G |
Snrpe |
small nuclear ribonucleoprotein polypeptide E |
|
multiple interactions |
ISO |
13 |
46,522,340 |
46,528,589 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Spc24 |
SPC24, NDC80 kinetochore complex component |
|
decreases expression |
ISO |
8 |
20,854,434 |
20,859,121 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
affects expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression |
EXP |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
increases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
multiple interactions |
ISO |
20 |
27,397,527 |
27,425,914 |
RGD:6480464 |
CTD |
| G |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
affects expression |
ISO |
20 |
27,397,527 |
27,425,914 |
RGD:6480464 |
CTD |
| G |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
decreases expression |
ISO |
20 |
27,397,527 |
27,425,914 |
RGD:6480464 |
CTD |
| G |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
decreases expression |
EXP |
20 |
27,397,527 |
27,425,914 |
RGD:6480464 |
CTD |
| G |
Stard6 |
StAR-related lipid transfer (START) domain containing 6 |
|
increases expression |
ISO |
18 |
67,186,100 |
67,203,069 |
RGD:6480464 |
CTD |
| G |
Stard6 |
StAR-related lipid transfer (START) domain containing 6 |
|
multiple interactions |
ISO |
18 |
67,186,100 |
67,203,069 |
RGD:6480464 |
CTD |
| G |
Stk38l |
serine/threonine kinase 38 like |
|
multiple interactions |
ISO |
4 |
184,316,579 |
184,392,709 |
RGD:6480464 |
CTD |
| G |
Stk38l |
serine/threonine kinase 38 like |
|
increases expression |
ISO |
4 |
184,316,579 |
184,392,709 |
RGD:6480464 |
CTD |
| G |
Stub1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
10 |
15,096,150 |
15,098,431 |
RGD:6480464 |
CTD |
| G |
Stub1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
10 |
15,096,150 |
15,098,431 |
RGD:6480464 |
CTD |
| G |
Styxl2 |
serine/threonine/tyrosine interacting protein-like2 |
|
increases expression |
ISO |
7 |
60,137,562 |
60,138,233 |
RGD:6480464 |
CTD |
| G |
Styxl2 |
serine/threonine/tyrosine interacting protein-like2 |
|
multiple interactions |
ISO |
7 |
60,137,562 |
60,138,233 |
RGD:6480464 |
CTD |
| G |
Sugp2 |
SURP and G patch domain containing 2 |
|
affects expression |
ISO |
16 |
19,644,374 |
19,673,741 |
RGD:6480464 |
CTD |
| G |
Supt3h |
suppressor of Ty 3 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
9 |
11,492,552 |
11,831,246 |
RGD:6480464 |
CTD |
| G |
Taf3 |
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa |
|
increases expression |
ISO |
17 |
79,770,612 |
79,946,159 |
RGD:6480464 |
CTD |
| G |
Taf3 |
TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa |
|
multiple interactions |
ISO |
17 |
79,770,612 |
79,946,159 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
multiple interactions |
ISO |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
decreases expression |
EXP |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Tgs1 |
trimethylguanosine synthase 1 |
|
affects expression |
ISO |
5 |
16,818,391 |
16,851,916 |
RGD:6480464 |
CTD |
| G |
Thap2 |
THAP domain containing, apoptosis associated protein 2 |
|
affects expression |
ISO |
7 |
54,644,248 |
54,655,301 |
RGD:6480464 |
CTD |
| G |
Them5 |
thioesterase superfamily member 5 |
|
decreases expression |
EXP |
2 |
189,315,151 |
189,321,030 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
affects expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
multiple interactions |
ISO |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tpd52 |
tumor protein D52 |
|
increases expression |
EXP |
2 |
94,850,203 |
94,880,802 |
RGD:6480464 |
CTD |
| G |
Tyk2 |
tyrosine kinase 2 |
|
multiple interactions |
ISO |
8 |
20,096,969 |
20,149,004 |
RGD:6480464 |
CTD |
| G |
Ubap2l |
ubiquitin associated protein 2-like |
|
multiple interactions |
ISO |
2 |
182,236,653 |
182,274,323 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
affects expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
increases expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
multiple interactions |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression |
ISO |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
multiple interactions |
ISO |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
increases expression |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
multiple interactions |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
affects expression |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
|
multiple interactions |
ISO |
5 |
136,255,481 |
136,263,676 |
RGD:6480464 |
CTD |
| G |
Uqcrh |
ubiquinol-cytochrome c reductase hinge protein |
|
increases expression |
ISO |
5 |
136,255,481 |
136,263,676 |
RGD:6480464 |
CTD |
| G |
Usp21 |
ubiquitin specific peptidase 21 |
|
multiple interactions |
ISO |
13 |
87,175,527 |
87,181,024 |
RGD:6480464 |
CTD |
| G |
Wdr4 |
WD repeat domain 4 |
|
increases expression |
ISO |
20 |
9,925,854 |
9,942,051 |
RGD:6480464 |
CTD |
| G |
Wdr4 |
WD repeat domain 4 |
|
multiple interactions |
ISO |
20 |
9,925,854 |
9,942,051 |
RGD:6480464 |
CTD |
| G |
Wdr47 |
WD repeat domain 47 |
|
increases expression |
ISO |
2 |
204,159,071 |
204,236,688 |
RGD:6480464 |
CTD |
| G |
Wdr47 |
WD repeat domain 47 |
|
multiple interactions |
ISO |
2 |
204,159,071 |
204,236,688 |
RGD:6480464 |
CTD |
| G |
Wdr8 |
WD repeat domain 8 |
|
multiple interactions |
ISO |
5 |
171,103,735 |
171,109,776 |
RGD:6480464 |
CTD |
| G |
Yif1a |
Yip1 interacting factor homolog A (S. cerevisiae) |
|
increases expression |
ISO |
1 |
207,711,277 |
207,715,338 |
RGD:6480464 |
CTD |
| G |
Yif1a |
Yip1 interacting factor homolog A (S. cerevisiae) |
|
multiple interactions |
ISO |
1 |
207,711,277 |
207,715,338 |
RGD:6480464 |
CTD |
| G |
Ypel1 |
yippee-like 1 (Drosophila) |
|
multiple interactions |
ISO |
11 |
85,929,479 |
85,936,364 |
RGD:6480464 |
CTD |
| G |
Zfp42 |
zinc finger protein 42 |
|
multiple interactions |
ISO |
16 |
52,150,048 |
52,158,306 |
RGD:6480464 |
CTD |
| G |
Znrf1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
19 |
41,455,386 |
41,537,955 |
RGD:6480464 |
CTD |
| G |
Znrf1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
19 |
41,455,386 |
41,537,955 |
RGD:6480464 |
CTD |
Term paths to the root
|